0001600438--04-302022Q1falseus-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationus-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization00016004382021-05-012021-07-31xbrli:shares00016004382021-08-31iso4217:USD00016004382021-07-3100016004382021-04-30iso4217:USDxbrli:shares00016004382020-05-012020-07-310001600438us-gaap:CommonStockMember2021-04-300001600438us-gaap:AdditionalPaidInCapitalMember2021-04-300001600438us-gaap:RetainedEarningsMember2021-04-300001600438us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-300001600438us-gaap:RetainedEarningsMember2021-05-012021-07-310001600438us-gaap:CommonStockMember2021-05-012021-07-310001600438us-gaap:AdditionalPaidInCapitalMember2021-05-012021-07-310001600438us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-05-012021-07-310001600438us-gaap:CommonStockMember2021-07-310001600438us-gaap:AdditionalPaidInCapitalMember2021-07-310001600438us-gaap:RetainedEarningsMember2021-07-310001600438us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-310001600438us-gaap:CommonStockMember2020-04-300001600438us-gaap:AdditionalPaidInCapitalMember2020-04-300001600438us-gaap:RetainedEarningsMember2020-04-300001600438us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-3000016004382020-04-300001600438us-gaap:RetainedEarningsMember2020-05-012020-07-310001600438us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-05-012020-07-310001600438us-gaap:AdditionalPaidInCapitalMember2020-05-012020-07-310001600438us-gaap:CommonStockMember2020-05-012020-07-310001600438us-gaap:CommonStockMember2020-07-310001600438us-gaap:AdditionalPaidInCapitalMember2020-07-310001600438us-gaap:RetainedEarningsMember2020-07-310001600438us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-3100016004382020-07-31gms:center0001600438gms:UninsuredRiskGeneralLiabilityInsuranceMember2021-07-310001600438gms:UninsuredRiskWorkersCompensationInsuranceMember2021-07-310001600438gms:UninsuredRiskAutomobileInsuranceMember2021-07-310001600438gms:UninsuredRiskGeneralLiabilityWorkersCompensationAndAutomobileMembersrt:MaximumMember2021-07-310001600438gms:UninsuredRiskGeneralLiabilityWorkersCompensationAndAutomobileMembersrt:MinimumMember2021-07-310001600438gms:UninsuredRiskGeneralLiabilityWorkersCompensationAndAutomobileMemberus-gaap:OtherCurrentLiabilitiesMember2021-07-310001600438gms:UninsuredRiskGeneralLiabilityWorkersCompensationAndAutomobileMemberus-gaap:OtherCurrentLiabilitiesMember2021-04-300001600438gms:UninsuredRiskGeneralLiabilityWorkersCompensationAndAutomobileMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-07-310001600438gms:UninsuredRiskGeneralLiabilityWorkersCompensationAndAutomobileMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-04-300001600438gms:WestsideBuildingMaterialMember2021-07-012021-07-01gms:location0001600438stpr:CAgms:WestsideBuildingMaterialMember2021-07-012021-07-010001600438stpr:NVgms:WestsideBuildingMaterialMember2021-07-012021-07-010001600438gms:WestsideBuildingMaterialMember2021-07-010001600438us-gaap:CustomerRelationshipsMembergms:WestsideBuildingMaterialMember2021-07-010001600438us-gaap:TradeNamesMembergms:WestsideBuildingMaterialMember2021-07-010001600438us-gaap:CustomerRelationshipsMembergms:WestsideBuildingMaterialMember2021-07-012021-07-010001600438us-gaap:TradeNamesMembergms:WestsideBuildingMaterialMember2021-07-012021-07-010001600438us-gaap:CustomerRelationshipsMembersrt:MinimumMember2021-05-012021-07-310001600438us-gaap:CustomerRelationshipsMembersrt:MaximumMember2021-05-012021-07-310001600438us-gaap:CustomerRelationshipsMember2021-05-012021-07-310001600438us-gaap:CustomerRelationshipsMember2021-07-310001600438srt:MinimumMemberus-gaap:TradeNamesMember2021-05-012021-07-310001600438us-gaap:TradeNamesMembersrt:MaximumMember2021-05-012021-07-310001600438us-gaap:TradeNamesMember2021-05-012021-07-310001600438us-gaap:TradeNamesMember2021-07-310001600438gms:VendorAgreementsMembersrt:MinimumMember2021-05-012021-07-310001600438gms:VendorAgreementsMembersrt:MaximumMember2021-05-012021-07-310001600438gms:VendorAgreementsMember2021-05-012021-07-310001600438gms:VendorAgreementsMember2021-07-310001600438us-gaap:DevelopedTechnologyRightsMember2021-05-012021-07-310001600438us-gaap:DevelopedTechnologyRightsMember2021-07-310001600438srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2021-05-012021-07-310001600438srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2021-05-012021-07-310001600438us-gaap:OtherIntangibleAssetsMember2021-05-012021-07-310001600438us-gaap:OtherIntangibleAssetsMember2021-07-310001600438us-gaap:CustomerRelationshipsMembersrt:MinimumMember2020-05-012021-04-300001600438us-gaap:CustomerRelationshipsMembersrt:MaximumMember2020-05-012021-04-300001600438us-gaap:CustomerRelationshipsMember2020-05-012021-04-300001600438us-gaap:CustomerRelationshipsMember2021-04-300001600438srt:MinimumMemberus-gaap:TradeNamesMember2020-05-012021-04-300001600438us-gaap:TradeNamesMembersrt:MaximumMember2020-05-012021-04-300001600438us-gaap:TradeNamesMember2020-05-012021-04-300001600438us-gaap:TradeNamesMember2021-04-300001600438gms:VendorAgreementsMembersrt:MinimumMember2020-05-012021-04-300001600438gms:VendorAgreementsMembersrt:MaximumMember2020-05-012021-04-300001600438gms:VendorAgreementsMember2020-05-012021-04-300001600438gms:VendorAgreementsMember2021-04-300001600438us-gaap:DevelopedTechnologyRightsMember2020-05-012021-04-300001600438us-gaap:DevelopedTechnologyRightsMember2021-04-300001600438srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2020-05-012021-04-300001600438srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2020-05-012021-04-300001600438us-gaap:OtherIntangibleAssetsMember2020-05-012021-04-300001600438us-gaap:OtherIntangibleAssetsMember2021-04-300001600438gms:DepreciationAndAmortizationExpenseMember2021-05-012021-07-310001600438gms:DepreciationAndAmortizationExpenseMember2020-05-012020-07-310001600438gms:FirstLienTermLoanDue2025Member2021-07-310001600438gms:FirstLienTermLoanDue2025Member2021-04-300001600438us-gaap:SeniorNotesMember2021-07-310001600438us-gaap:SeniorNotesMember2021-04-300001600438gms:AssetBasedLendingCreditFacilityDatedAsOf2014April01Member2021-07-310001600438gms:AssetBasedLendingCreditFacilityDatedAsOf2014April01Member2021-04-30xbrli:pure0001600438gms:InstallmentNotes5.0PercentMember2021-07-310001600438gms:InstallmentNotes5.0PercentMember2021-04-300001600438gms:TitanRevolvingCreditFacilityMember2021-07-310001600438gms:TitanRevolvingCreditFacilityMember2021-04-300001600438gms:FirstLienTermLoanDue2025Member2021-05-012021-07-310001600438us-gaap:LondonInterbankOfferedRateLIBORMembergms:FirstLienTermLoanDue2025Member2021-05-012021-07-310001600438gms:SwingLineMembergms:AssetBasedLendingCreditFacilityDatedAsOf2014April01Member2021-07-31iso4217:CAD0001600438gms:FinanceLeaseObligationsMember2021-07-310001600438srt:MaximumMember2021-07-310001600438us-gaap:AccumulatedTranslationAdjustmentMember2021-04-300001600438us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-300001600438us-gaap:AccumulatedTranslationAdjustmentMember2021-05-012021-07-310001600438us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-05-012021-07-310001600438us-gaap:AccumulatedTranslationAdjustmentMember2021-07-310001600438us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-310001600438us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-05-012021-07-310001600438us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-05-012020-07-310001600438us-gaap:EmployeeStockOptionMember2021-04-300001600438us-gaap:EmployeeStockOptionMember2020-05-012021-04-300001600438us-gaap:EmployeeStockOptionMember2021-05-012021-07-310001600438us-gaap:EmployeeStockOptionMember2021-07-310001600438us-gaap:EmployeeStockOptionMember2020-05-012020-07-310001600438us-gaap:RestrictedStockUnitsRSUMember2021-04-300001600438us-gaap:RestrictedStockUnitsRSUMember2021-05-012021-07-310001600438us-gaap:RestrictedStockUnitsRSUMember2021-07-310001600438gms:EmployeeStockPurchasePlanMember2021-05-012021-07-310001600438gms:EmployeeStockPurchasePlanMember2021-07-310001600438gms:EmployeeStockPurchasePlanMember2020-05-012020-07-310001600438gms:EmployeeStockPurchasePlanMember2020-07-310001600438us-gaap:StockAppreciationRightsSARSMember2021-04-300001600438gms:ShareholderDeferredCompensationMember2021-04-300001600438gms:NoncontrollingInterestAwardMember2021-04-300001600438us-gaap:StockAppreciationRightsSARSMember2021-05-012021-07-310001600438gms:ShareholderDeferredCompensationMember2021-05-012021-07-310001600438gms:NoncontrollingInterestAwardMember2021-05-012021-07-310001600438us-gaap:StockAppreciationRightsSARSMember2021-07-310001600438gms:ShareholderDeferredCompensationMember2021-07-310001600438gms:NoncontrollingInterestAwardMember2021-07-310001600438us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-07-310001600438us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-04-300001600438us-gaap:InterestRateSwapMembergms:FirstLienTermLoanDue2025Member2019-02-280001600438us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:InterestRateSwapMembergms:FirstLienTermLoanDue2025Member2019-02-280001600438us-gaap:InterestRateSwapMember2021-07-310001600438us-gaap:InterestRateSwapMemberus-gaap:OtherLiabilitiesMember2021-07-310001600438us-gaap:InterestRateSwapMember2021-05-012021-07-310001600438us-gaap:InterestRateSwapMember2020-05-012020-07-310001600438gms:OtherAccruedExpensesAndCurrentLiabilitiesMemberus-gaap:InterestRateSwapMember2021-05-012021-07-310001600438us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-07-310001600438us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-07-310001600438us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-04-300001600438us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-04-300001600438us-gaap:OperatingSegmentsMember2021-05-012021-07-310001600438us-gaap:MaterialReconcilingItemsMember2021-05-012021-07-310001600438us-gaap:CorporateNonSegmentMember2021-05-012021-07-310001600438us-gaap:OperatingSegmentsMember2020-05-012020-07-310001600438us-gaap:MaterialReconcilingItemsMember2020-05-012020-07-310001600438us-gaap:CorporateNonSegmentMember2020-05-012020-07-310001600438gms:WallboardMember2021-05-012021-07-310001600438gms:WallboardMember2020-05-012020-07-310001600438gms:CeilingsMember2021-05-012021-07-310001600438gms:CeilingsMember2020-05-012020-07-310001600438gms:SteelFramingMember2021-05-012021-07-310001600438gms:SteelFramingMember2020-05-012020-07-310001600438gms:OtherProductsMember2021-05-012021-07-310001600438gms:OtherProductsMember2020-05-012020-07-310001600438country:US2021-05-012021-07-310001600438country:US2020-05-012020-07-310001600438country:CA2021-05-012021-07-310001600438country:CA2020-05-012020-07-310001600438country:US2021-07-310001600438country:US2021-04-300001600438country:CA2021-07-310001600438country:CA2021-04-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 31, 2021
OR
☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________ to _______________.
COMMISSION FILE NUMBER: 001-37784
______________________________________________________________

GMS INC.
(Exact name of registrant as specified in its charter)
______________________________________________________________
Delaware 46-2931287
(State or other jurisdiction of incorporation (IRS Employer Identification No.)
or organization)
100 Crescent Centre Parkway, Suite 800
Tucker,
Georgia 30084
(Address of principal executive offices) (ZIP Code)
(800) 392-4619
(Registrant’s telephone number, including area code)

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of each class Trading Symbol(s) Name of each exchanged on which registered
Common Stock, par value $0.01 per share GMS New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesNo ◻
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YesNo
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
     Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
There were 43,148,444 shares of the registrant’s common stock, par value $0.01 per share, outstanding as of August 31, 2021.



FORM 10-Q
TABLE OF CONTENTS
Page
3
PART I
5
Item 1
5
5
6
7
8
9
Item 2
24
Item 3
33
Item 4
33
PART II
34
Item 1
34
Item 1A
34
Item 2
34
Item 3
34
Item 4
35
Item 5
35
Item 6
36
37

2


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). You can generally identify forward-looking statements by our use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “seek,” or “should,” or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the growth of our various markets, and statements about our expectations, beliefs, plans, strategies, objectives, prospects, assumptions or future events or performance contained in this Quarterly Report on Form 10-Q are forward-looking statements.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed under the heading “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2021, filed with the U.S. Securities and Exchange Commission (the “SEC”), may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include:

the negative impact of the COVID-19 pandemic (which, among other things, may exacerbate each of the risks listed below);
general economic and financial conditions;
our dependency upon the commercial and residential construction and residential repair and remodeling, or R&R, markets;
competition in our highly fragmented industry and the markets in which we operate;
the fluctuations in prices and mix of the products we distribute and our ability to pass on price increases to our customers, including as a result of inflationary and deflationary pressures;
the consolidation of our industry;
our ability to successfully implement our strategic initiatives, which include pursuing growth through acquisitions and greenfield branch expansion, as well as cost reduction and productivity initiatives;
our ability to expand into new geographic markets;
product shortages, other disruptions in our supply chain or distribution network and potential loss of relationships with key suppliers;
the seasonality of the commercial and residential construction markets;
the potential loss of any significant customers and the reduction of the quantity of products our customers purchase;
exposure to product liability and various other claims and litigation, and the adequacy of insurance related thereto;
operating hazards that may cause personal injury or property damage;
our ability to attract and retain key employees;
rising health care and labor costs and the impact of labor and trucking shortages;
the credit risk from our customers;
3


our ability to renew leases for our facilities on favorable terms or identify new facilities;
our ability to effectively manage our inventory as our sales volume or the prices of the products we distribute fluctuate;
the impact of federal, state, provincial and local regulations, including potential changes in our effective tax rate;
the cost of compliance with environmental, health and safety laws and other regulations;
significant fluctuations in fuel costs or shortages in the supply of fuel;
a cybersecurity breach, including misappropriation of our customers’, employees’ or suppliers’ confidential information, and the potential costs related thereto;
a disruption in our IT systems and costs necessary to maintain and update our IT systems;
natural or man-made disruptions to our facilities;
the risk of our Canadian operations, including currency rate fluctuations;
the imposition of tariffs and other trade barriers, and the effect of retaliatory trade measures;
our inability to engage in activities that may be in our best long-term interests because of restrictions in our debt agreements;
our current level of indebtedness and our potential to incur additional indebtedness; and
our ability to obtain additional financing on acceptable terms, if at all.

Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements contained in this Quarterly Report on Form 10-Q are not guarantees of future performance and actual results and events may differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q.
Any forward-looking statement that we make in this Quarterly Report on Form 10-Q speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this Quarterly Report on Form 10-Q. You should review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of the filing of this Quarterly Report on Form 10-Q.
4


PART I – Financial Information
Item 1. Financial Statements
GMS Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except per share data)
July 31,
2021
April 30,
2021
Assets
Current assets:   
Cash and cash equivalents $ 43,590  $ 167,012 
Trade accounts and notes receivable, net of allowances of $6,989 and $6,282, respectively
656,878  558,661 
Inventories, net 470,249  357,054 
Prepaid expenses and other current assets 21,812  19,525 
Total current assets 1,192,529  1,102,252 
Property and equipment, net of accumulated depreciation of $201,441 and $193,364, respectively
323,967  311,326 
Operating lease right-of-use assets 138,279  118,413 
Goodwill 587,331  576,330 
Intangible assets, net 395,647  350,869 
Deferred income taxes 17,584  15,715 
Other assets 8,744  8,993 
Total assets $ 2,664,081  $ 2,483,898 
Liabilities and Stockholders’ Equity
Current liabilities:      
Accounts payable $ 329,452  $ 322,965 
Accrued compensation and employee benefits 48,589  72,906 
Other accrued expenses and current liabilities 117,107  87,138 
Current portion of long-term debt 46,687  46,018 
Current portion of operating lease liabilities 36,437  33,474 
Total current liabilities 578,272  562,501 
Non-current liabilities:
Long-term debt, less current portion 1,016,036  932,409 
Long-term operating lease liabilities 102,196  90,290 
Deferred income taxes, net 15,055  12,728 
Other liabilities 75,279  63,508 
Total liabilities 1,786,838  1,661,436 
Commitments and contingencies
Stockholders' equity:
Common stock, par value $0.01 per share, 500,000 shares authorized; 43,083 and 43,073 shares issued and outstanding as of July 31, 2021 and April 30, 2021, respectively
431  431 
Preferred stock, par value $0.01 per share, 50,000 shares authorized; 0 shares issued and outstanding as of July 31, 2021 and April 30, 2021
—  — 
Additional paid-in capital 542,587  542,737 
Retained earnings 335,737  274,535 
Accumulated other comprehensive (loss) income (1,512) 4,759 
Total stockholders' equity 877,243  822,462 
Total liabilities and stockholders' equity $ 2,664,081  $ 2,483,898 

The accompanying notes are an integral part of these condensed consolidated financial statements.
5


GMS Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)
(in thousands, except per share data)
Three Months Ended
July 31,
2021 2020
Net sales $ 1,042,076  $ 802,573 
Cost of sales (exclusive of depreciation and amortization shown separately below) 706,243  542,115 
Gross profit 335,833  260,458 
Operating expenses:
Selling, general and administrative 214,081  183,112 
Depreciation and amortization 27,714  27,097 
Total operating expenses 241,795  210,209 
Operating income 94,038  50,249 
Other (expense) income:
Interest expense (13,657) (14,081)
Other income, net 792  655 
Total other expense, net (12,865) (13,426)
Income before taxes 81,173  36,823 
Provision for income taxes 19,971  9,604 
Net income $ 61,202  $ 27,219 
Weighted average common shares outstanding:
Basic 43,089  42,624 
Diluted 43,972  43,017 
Net income per common share:
Basic $ 1.42  $ 0.64 
Diluted $ 1.39  $ 0.63 
Comprehensive income
Net income $ 61,202  $ 27,219 
Foreign currency translation (loss) income (8,233) 16,281 
Changes in other comprehensive income, net of tax 1,962  959 
Comprehensive income $ 54,931  $ 44,459 

The accompanying notes are an integral part of these condensed consolidated financial statements.
6


GMS Inc.
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
(in thousands)
Common Stock Additional
 Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total
Stockholders'
Equity
Shares Amount
Balances as of April 30, 2021 43,073  $ 431  $ 542,737  $ 274,535  $ 4,759  $ 822,462 
Net income —  —  —  61,202  —  61,202 
Repurchase and retirement of common stock (85) (1) (3,854) —  —  (3,855)
Foreign currency translation adjustments —  —  —  —  (8,233) (8,233)
Other comprehensive income, net of tax —  —  —  —  1,962  1,962 
Equity-based compensation —  —  1,958  —  —  1,958 
Exercise of stock options 44  862  —  —  863 
Vesting of restricted stock units —  —  —  —  — 
Tax withholding related to net share settlements of equity awards —  —  (256) —  —  (256)
Issuance of common stock pursuant to employee stock purchase plan 43  —  1,140  —  —  1,140 
Balances as of July 31, 2021 43,083  $ 431  $ 542,587  $ 335,737  $ (1,512) $ 877,243 

Common Stock Additional
Paid-in
 Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
Total
Stockholders'
Equity
Shares Amount
Balances as of April 30, 2020 42,554  $ 426  $ 529,662  $ 168,975  $ (65,082) $ 633,981 
Net income —  —  —  27,219  —  27,219 
Foreign currency translation adjustments —  —  —  —  16,281  16,281 
Other comprehensive income, net of tax —  —  —  —  959  959 
Equity-based compensation —  —  1,575  —  —  1,575 
Exercise of stock options 54  —  691  —  —  691 
Vesting of restricted stock units —  —  —  —  — 
Tax withholding related to net share settlements of equity awards —  —  (105) —  —  (105)
Issuance of common stock pursuant to employee stock purchase plan 58  1,269  —  —  1,270 
Balances as of July 31, 2020 42,673  $ 427  $ 533,092  $ 196,194  $ (47,842) $ 681,871 
The accompanying notes are an integral part of these condensed consolidated financial statements.

7


GMS Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Three Months Ended
July 31,
2021 2020
Cash flows from operating activities:   
Net income $ 61,202  $ 27,219 
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization 27,714  27,097 
Amortization of debt discount and debt issuance costs 642  753 
Equity-based compensation 3,160  2,619 
(Gain) loss on disposal and impairment of assets (78) 394 
Deferred income taxes (140) (5,241)
Other items, net 1,573  247 
Changes in assets and liabilities net of effects of acquisitions:
Trade accounts and notes receivable (73,479) (23,013)
Inventories (87,313) 14,008 
Prepaid expenses and other assets (1,491) (3,782)
Accounts payable (4,265) (33,887)
Accrued compensation and employee benefits (24,219) (36,062)
Other accrued expenses and liabilities 21,617  13,937 
Cash used in operating activities (75,077) (15,711)
Cash flows from investing activities:
Purchases of property and equipment (6,814) (4,745)
Proceeds from sale of assets 287  342 
Acquisition of businesses, net of cash acquired (123,049) (210)
Cash used in investing activities (129,576) (4,613)
Cash flows from financing activities:
Repayments on revolving credit facilities (102,872) (58,083)
Borrowings from revolving credit facilities 195,049  14,421 
Payments of principal on long-term debt (1,278) (2,492)
Payments of principal on finance lease obligations (7,397) (7,521)
Repurchases of common stock (3,855) — 
Proceeds from exercises of stock options 863  691 
Payments for taxes related to net share settlement of equity awards (256) (105)
Other financing activities 1,140  1,270 
Cash provided by (used in) financing activities 81,394  (51,819)
Effect of exchange rates on cash and cash equivalents (163) 943 
Decrease in cash and cash equivalents (123,422) (71,200)
Cash and cash equivalents, beginning of period 167,012  210,909 
Cash and cash equivalents, end of period $ 43,590  $ 139,709 
Supplemental cash flow disclosures:
Cash paid for income taxes $ 1,007  $ 3,478 
Cash paid for interest 8,616  13,115 
The accompanying notes are an integral part of these condensed consolidated financial statements.
8


GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies
Business
Founded in 1971, GMS Inc. (“we,” “our,” “us,” or the “Company”), through its wholly-owned operating subsidiaries, is a distributor of specialty building products including wallboard, suspended ceilings systems, or ceilings, steel framing and other complementary building products. We purchase products from many manufacturers and then distribute these goods to a customer base consisting of wallboard and ceilings contractors and homebuilders and, to a lesser extent, general contractors and individuals. We operate a network of more than 280 distribution centers across the United States and Canada.
Basis of Presentation
The condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all normal and recurring adjustments necessary for a fair presentation of the results of operations, financial position and cash flows. All adjustments are of a normal recurring nature unless otherwise disclosed. The results of operations for interim periods are not necessarily indicative of results for any other interim period or the entire fiscal year. As a result, the unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.
Principles of Consolidation
The condensed consolidated financial statements present the results of operations, financial position, stockholders’ equity and cash flows of the Company and its subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. The results of operations of businesses acquired are included from their respective dates of acquisition.
Use of Estimates
The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Foreign Currency Translation
Assets and liabilities of the Company’s Canadian subsidiaries are translated at the exchange rate prevailing at the balance sheet date, while income and expenses are translated at average rates for the period. Translation gains and losses are reported as a separate component of stockholders’ equity and other comprehensive income (loss). Gains and losses on foreign currency transactions are recognized in the Condensed Consolidated Statements of Operations and Comprehensive Income within other (expense) income, net.
Insurance Liabilities
The Company is self-insured for certain losses related to medical claims. The Company has stop-loss coverage to limit the exposure arising from medical claims. In addition, the Company has deductible-based insurance policies for certain losses related to general liability, workers’ compensation and automobile. The coverage consists of a deductible layer, a primary layer, a self-insured buffer layer, a lead umbrella layer and excess layers. The deductible amount per incident is $0.5 million, $1.0 million and $2.5 million for general liability, workers’ compensation and automobile, respectively. The primary layer of coverage is from $0.3 million, $0.5 million and $1.0 million for general liability, workers’ compensation, and automobile liability, respectively, to $5.0 million. The Company self-insures a buffer layer from $5.0 million to $10.0 million. The umbrella and excess layers cover claims from $10.0 million to $100.0 million. The expected ultimate cost for claims incurred as of the balance sheet date is not discounted and is recognized as a liability. Insurance losses for claims filed and claims incurred but not reported are accrued based upon estimates of the aggregate liability for uninsured claims using historical loss development factors and actuarial assumptions followed in the insurance industry.
9

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

The following table presents the Company’s aggregate liabilities for medical self-insurance, reserves for general liability, automobile and workers’ compensation and the expected recoveries for medical self-insurance, general liability, automobile and workers’ compensation. Liabilities for medical self-insurance are included in other accrued expenses and current liabilities. Reserves for general liability, automobile and workers’ compensation are included in other accrued expenses and current liabilities and other liabilities. Expected recoveries for insurance liabilities are included in prepaid expenses and other current assets and other assets in the Condensed Consolidated Balance Sheets.
July 31,
2021
April 30,
2021
(in thousands)
Medical self‑insurance $ 3,736  $ 3,852 
General liability, automobile and workers’ compensation 18,146  19,807 
Expected recoveries for insurance liabilities (3,208) (3,209)

Revenue Recognition
Revenue is recognized upon transfer of control of promised goods to customers at an amount that reflects the consideration the Company expects to receive in exchange for those goods. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. The Company includes shipping and handling costs billed to customers in net sales. These costs are recognized as a component of selling, general and administrative expenses.
See Note 13, “Segments,” for information regarding disaggregation of revenue, including revenue by product and by geographic area.
Income Taxes
The Company considers each interim period an integral part of the annual period and measures tax expense (benefit) using an estimated annual effective income tax rate. Estimates of the annual effective income tax rate at the end of interim periods are, out of necessity, based on evaluation of possible future events and transactions and may be subject to subsequent refinement or revision. The Company forecasts its estimated annual effective income tax rate and then applies that rate to its year-to-date pre-tax ordinary income (loss), subject to certain loss limitation provisions. In addition, certain specific transactions are excluded from the Company’s estimated annual effective tax rate computation, but are discretely recognized within income tax expense (benefit) in their respective interim period. Future changes in the forecasted annual income (loss) projections, tax rate changes, or discrete tax items could result in significant adjustments to quarterly income tax expense (benefit) in future periods.
The Company evaluates its deferred tax assets quarterly to determine if valuation allowances are required. In this evaluation, the Company considers both positive and negative evidence in determining whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The primary negative evidence considered includes the cumulative operating losses generated in prior periods. The primary positive evidence considered includes the reversal of deferred tax liabilities primarily related to depreciation and amortization that would occur within the same jurisdiction and during the carryforward period necessary to absorb the federal and state net operating losses and other deferred tax assets.
Deferred tax assets and liabilities are computed by applying the federal, provincial and state income tax rates in effect to the gross amounts of temporary differences and other tax attributes, such as net operating loss carry-forwards. In assessing if the deferred tax assets will be realized, the Company considers whether it is more likely than not that some or all of these deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which these deductible temporary differences reverse.
Earnings Per Share
Basic earnings per share is computed by dividing net income available to common stockholders by the weighted average number of outstanding shares of common stock for the period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock, including stock options and restricted stock units (collectively “Common Stock Equivalents”), were exercised or converted into common stock. The dilutive effect of outstanding stock options and restricted stock units is reflected in diluted earnings per share by application of the treasury stock method. In
10

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amount of compensation cost attributed to future services and not yet recognized. Diluted earnings per share is computed by increasing the weighted-average number of outstanding shares of common stock computed in basic earnings per share to include the dilutive effect of Common Stock Equivalents for the period. In periods of net loss, the number of shares used to calculate diluted loss per share is the same as basic net loss per share.
Reclassifications
Certain amounts in the prior period financial statements have been reclassified to conform to the current year presentation. 
Recently Issued Accounting Pronouncements
Reference Rate Reform – In March 2020, the Financial Accounting Standards Board ("FASB") issued new guidance to temporarily ease the potential burden in accounting for reference rate reform. The guidance provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by reference rates that are expected to be discontinued, such as the London Interbank Offered Rate ("LIBOR"). The guidance was effective upon issuance and generally can be applied through December 31, 2022. The Company expects to elect optional expedients and exceptions provided by the guidance, as needed, related to its debt instruments, which include interest rates based on a LIBOR rate. The Company will evaluate and disclose the impact of this guidance in the period of election, as well as the nature and reason for doing so.
2. Business Combinations
The Company accounts for business combinations by recognizing the assets acquired and liabilities assumed at the acquisition date fair value. In valuing certain acquired assets and liabilities, fair value estimates use Level 3 inputs, including future expected cash flows and discount rates. Goodwill is measured as the excess of consideration transferred over the fair values of the assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to value assets acquired and liabilities assumed at the acquisition date, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments arising from new facts and circumstances are recorded to the Consolidated Statements of Operations and Comprehensive Income. The results of operations of acquisitions are reflected in the Company’s Consolidated Financial Statements from the date of acquisition.
Westside Acquisition
On July 1, 2021, the Company acquired substantially all the assets of Westside Building Material ("Westside"), one of the largest independent distributors of interior building products in the U.S., for preliminary consideration of $139.6 million. Westside is a leading supplier of steel framing, wallboard, acoustical ceilings, insulation and related building products serving commercial and residential markets. Westside’s distribution network comprises ten locations, including nine across California (Anaheim, Hesperia, Oakland, Chatsworth, Fresno, Lancaster, Santa Maria, San Diego and National City) and one in Las Vegas, Nevada. The primary purpose of the transaction was to expand the geographical coverage of the Company and grow the business.
The assets acquired and liabilities assumed were recognized at their acquisition date fair values. Due to the limited amount of time since the acquisition of Westside, the acquisition accounting is subject to change as the Company obtains additional information during the measurement period about the facts and circumstances that existed as of the acquisition date. The primary areas of the preliminary acquisition accounting that are not yet finalized relate to working capital adjustments, the finalization of preliminary fair value estimates and residual goodwill.
11

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

The following table summarizes the components of the preliminary consideration:
(in thousands)
Cash consideration $ 122,635 
Holdback liability 17,000 
Total preliminary consideration transferred $ 139,635 
Included in the total preliminary consideration is a $17.0 million holdback liability, of which $3.5 million is for working capital adjustments that will be settled 150 days after the acquisition date and $13.5 million is for general representations and warranties of the sellers that will be settled 15 months after the acquisition date.
The following table summarizes the preliminary acquisition accounting for this acquisition based on currently available information:
Preliminary
Acquisition
Accounting
(in thousands)
Trade accounts and notes receivable $ 27,081 
Inventories 28,900 
Prepaid and other current assets 228 
Property and equipment 17,136 
Operating lease right-of-use assets 20,782 
Customer relationships 51,500 
Tradenames 11,300 
Goodwill 12,902 
Accounts payable and accrued expenses (14,375)
Operating lease liabilities (15,819)
Fair value of consideration transferred $ 139,635 
Goodwill recognized is attributable to synergies achieved through the streamlining of operations combined with improved margins attainable through increased market presence and is all attributable to the Company's geographic divisions reportable segment. Goodwill is expected to be deductible for U.S. federal income tax purposes. The estimated useful life for the customer relationships is 12 years and the estimated useful life for the tradenames is 15 years. The pro forma impact of this acquisition is not presented as it is not considered material to the Company's Consolidated Financial Statements.
Other Acquisition
On June 3, 2021, the Company acquired the assets of Architectural Coatings Distributors, Inc. (“Architectural Coating”). Architectural Coating is an interior building products distributor in Cleveland, Ohio. The impact of this acquisition is not material to the Company’s Consolidated Financial Statements.
3. Accounts Receivable
The Company’s trade accounts and notes receivable consisted of the following:
July 31,
2021
April 30,
2021
(in thousands)
Trade receivables $ 563,604  $ 488,002 
Other receivables 100,263  76,941 
Allowance for expected credit losses (3,345) (3,254)
Other allowances (3,644) (3,028)
Trade accounts and notes receivable $ 656,878  $ 558,661 
12

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

The following table presents the change in the allowance for expected credit losses during the three months ended July 31, 2021:
(in thousands)
Balance as of April 30, 2021 $ 3,254 
Provision 53 
Other 38 
Balance as of July 31, 2021 $ 3,345 

Receivables from contracts with customers, net of allowances, were $556.6 million and $481.7 million as of July 31, 2021 and April 30, 2021, respectively. The Company did not have material amounts of contract assets or liabilities as of July 31, 2021 or April 30, 2021.

4. Goodwill and Intangible Assets
Goodwill
The following table presents changes in the carrying amount of goodwill:
Gross Accumulated Net
Carrying Amount Impairment Loss Carrying Amount
(in thousands)
Balance as of April 30, 2021 $ 645,377  $ (69,047) $ 576,330 
Goodwill recognized from acquisitions 13,057  —  13,057 
Translation adjustment (2,949) 893  (2,056)
Balance as of July 31, 2021 $ 655,485  $ (68,154) $ 587,331 
Intangible Assets
The following tables present the components of the Company’s definite-lived intangible assets:
Estimated
Useful
Lives
(years)
Weighted
Average
Amortization
Period
July 31, 2021
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Value
(dollars in thousands)
Customer relationships
5 - 16
12.7 $ 616,241  $ (342,161) $ 274,080 
Definite-lived tradenames
5 - 20
15.8 72,820  (15,803) 57,017 
Vendor agreements
8 - 10
8.3 6,644  (5,574) 1,070 
Developed technology 5 4.9 5,608  (3,612) 1,996 
Other
3 - 5
3.2 4,243  (4,126) 117 
Totals $ 705,556  $ (371,276) $ 334,280 
13

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

Estimated
Useful
Lives
(years)
Weighted
Average
Amortization
Period
April 30, 2021
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Value
(dollars in thousands)
Customer relationships
5 - 16
13.3 $ 569,255  $ (330,880) $ 238,375 
Definite-lived tradenames
5 - 20
16.8 62,084  (14,842) 47,242 
Vendor agreements
8 - 10
8.3 6,644  (5,372) 1,272 
Developed technology 5 4.9 5,699  (3,381) 2,318 
Other
3 - 5
3.3 4,291  (3,996) 295 
Totals $ 647,973  $ (358,471) $ 289,502 
Amortization expense related to definite-lived intangible assets was $14.8 million and $14.3 million for the three months ended July 31, 2021 and 2020, respectively.
The following table summarizes the estimated future amortization expense for definite-lived intangible assets. Actual amortization expense to be reported in future periods could differ materially from these estimates as a result of acquisitions, changes in useful lives, foreign currency exchange rate fluctuations and other relevant factors.
Year Ending April 30, (in thousands)
2022 (remaining nine months) $ 45,822 
2023 54,035 
2024 44,582 
2025 36,900 
2026 31,037 
Thereafter 121,904 
Total $ 334,280 
The Company’s indefinite-lived intangible assets consist of tradenames that had a carrying amount of $61.4 million as of July 31, 2021 and April 30, 2021.
5. Long-Term Debt
The Company’s long-term debt consisted of the following:
July 31,
2021
April 30,
2021
(in thousands)
Term Loan Facility $ 508,445  $ 509,722 
Unamortized discount and deferred financing costs on Term Loan Facility (4,444) (4,735)
Senior Notes 350,000  350,000 
Unamortized discount and deferred financing costs on Senior Notes (5,324) (5,485)
ABL Facility 87,100  — 
Finance lease obligations 112,906  117,948 
Installment notes at fixed rates up to 5.0%, due in monthly and annual installments through 2025
9,723  11,716 
Unamortized discount on installment notes (647) (739)
Canadian Facility 4,964  — 
Carrying value of debt 1,062,723  978,427 
Less current portion 46,687  46,018 
Long-term debt $ 1,016,036  $ 932,409 
14

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

Term Loan Facility
The Company has a senior secured first lien term loan facility (the “Term Loan Facility”). The Company is required to make scheduled quarterly payments of $1.3 million, or 0.25% of the aggregate principal amount of the Term Loan Facility, with the balance due in June 2025. The Term Loan Facility bears interest at a floating rate based on LIBOR plus 2.50%, with a 0% floor. As of July 31, 2021, the applicable rate of interest was 2.59%.
Senior Notes
The Company has senior unsecured notes due May 2029 (the "Senior Notes"). The Senior Notes bear interest at 4.625% per annum and mature on May 1, 2029. Interest is payable semi-annually in arrears on May 1 and November 1.
Asset Based Lending Facility
The Company has an asset based revolving credit facility (the “ABL Facility”) that provides for aggregate revolving commitments of $445.0 million (including same day swing line borrowings of $44.5 million). Extensions of credit under the ABL Facility are limited by a borrowing base calculated periodically based on specified percentages of the value of eligible inventory and eligible accounts receivable, subject to certain reserves and other adjustments.
At the Company’s option, the interest rates applicable to the loans under the ABL Facility are based on LIBOR or base rate plus, in each case, an applicable margin. The margins applicable for each elected interest rate are subject to a pricing grid, as defined in the ABL Facility agreement, based on average daily availability for the most recent fiscal quarter. The ABL Facility also contains an unused commitment fee. As of July 31, 2021, the applicable rate of interest was 3.50%.
As of July 31, 2021, the Company had available borrowing capacity of approximately $335.5 million under the ABL Facility. The ABL Facility matures on September 30, 2024 unless the individual affected lenders agree to extend the maturity of their respective loans under the ABL Facility upon the Company’s request and without the consent of any other lender. The ABL Facility contains a cross default provision with the Term Loan Facility.
Debt Covenants
The Term Loan Facility contains a number of covenants that limit our ability and the ability of our restricted subsidiaries, as described in the respective credit agreement, to: incur more indebtedness; pay dividends, redeem or repurchase stock or make other distributions; make investments; create restrictions on the ability of our restricted subsidiaries to pay dividends to us or make other intercompany transfers; create liens securing indebtedness; transfer or sell assets; merge or consolidate; enter into certain transactions with our affiliates; and prepay or amend the terms of certain indebtedness. The Company was in compliance with all covenants contained in the Term Loan Facility as of July 31, 2021.
The Senior Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to incur additional indebtedness, make certain dividends, repurchase Company stock or make other distributions, make certain investments, create liens, transfer or sell assets, merge or consolidate, and enter into transactions with the Company’s affiliates. Such covenants are subject to a number of important exceptions and qualifications set forth in the related indenture. The Company was in compliance with all covenants contained in the Senior Notes as of July 31, 2021.
The ABL Facility contains certain affirmative covenants, including financial and other reporting requirements. The Company was in compliance with all such covenants as of July 31, 2021.
Canadian Revolving Credit Facility
Through its WSB Titan (“Titan”) subsidiary, the Company has a revolving credit facility (the “Canadian Facility”) that provides for aggregate revolving commitments of $24.0 million ($30.0 million Canadian dollars). The Canadian Facility bears interest at the Canadian prime rate plus a marginal rate based on the level determined by Titan’s total debt to EBITDA ratio at the end of the most recently completed fiscal quarter or year. As of July 31, 2021, the Company had available borrowing capacity of approximately $19.1 million under the Canadian Facility. The Canadian Facility matures on January 12, 2026. As of July 31, 2021, the applicable rate of interest was 2.83%.
15

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

Debt Maturities
As of July 31, 2021, the maturities of long-term debt were as follows
Term Loan
Facility
Senior Notes ABL Facility Finance
Leases
Installment
Notes
Canadian Facility Total
Year Ending April 30, (in thousands)
2022 (remaining nine months) $ 3,833  $ —  $ —  $ 28,263  $ 2,464  $ —  $ 34,560 
2023 5,110  —  —  32,050  4,505  —  41,665 
2024 5,110  —  —  25,234  1,881  —  32,225 
2025 5,110  —  87,100  15,397  873  —  108,480 
2026 489,282  —  —  8,207  —  4,964  502,453 
Thereafter —  350,000  —  3,755  —  —  353,755 
$ 508,445  $ 350,000  $ 87,100  $ 112,906  $ 9,723  $ 4,964  $ 1,073,138 

6. Leases
The components of lease expense were as follows:
Three Months Ended
July 31,
2021 2020
(in thousands)
Finance lease cost:
Amortization of right-of-use assets $ 5,592  $ 6,139 
Interest on lease liabilities 2,301  3,062 
Operating lease cost 11,012  10,620 
Variable lease cost 3,861  2,999 
Total lease cost $ 22,766  $ 22,820 
Supplemental cash flow information related to leases was as follows:
Three Months Ended
July 31,
2021 2020
(in thousands)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases $ 11,189  $ 10,648 
Operating cash flows from finance leases 2,301  3,062 
Financing cash flows from finance leases 7,397  7,521 
Right-of-use assets obtained in exchange for lease obligations
Operating leases 24,210  6,843 
Finance leases 4,076  3,935 
16

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

Other information related to leases was as follows:
July 31,
2021
April 30,
2021
(in thousands)
Finance leases included in property and equipment
Property and equipment $ 175,852  $ 176,591 
Accumulated depreciation (53,609) (51,869)
Property and equipment, net $ 122,243  $ 124,722 
Weighted-average remaining lease term (years)
Operating leases 4.7 4.7
Finance leases 3.5 3.5
Weighted-average discount rate
Operating leases 5.2  % 5.5  %
Finance leases 4.6  % 4.6  %
Future minimum lease payments under non-cancellable leases as of July 31, 2021 were as follows:
Finance Operating
Year Ending April 30, (in thousands)
2022 (remaining nine months) $ 33,640  $ 32,773 
2023 36,159  38,059 
2024 26,971  32,185 
2025 16,060  22,412 
2026 8,415  12,584 
Thereafter 3,792  19,161 
Total lease payments 125,037  157,174 
Less imputed interest 12,131  18,541 
Total $ 112,906  $ 138,633 
7. Income Taxes
General. The Company’s effective income tax rate on continuing operations was 24.6% and 26.1% for the three months ended July 31, 2021 and 2020, respectively. The difference in the effective income tax rate over the U.S. federal statutory rate of 21.0% for the three months ended July 31, 2021 was primarily due to the impact of state and foreign taxes. The difference in the effective income tax rate over the U.S. federal statutory rate for the three months ended July 31, 2020 was primarily due to the impact of state taxes, foreign tax rates and a change in the valuation allowance.
Valuation allowance. The Company had a valuation allowance of $11.9 million and $11.8 million against its deferred tax assets related to certain U.S. tax jurisdictions as of July 31, 2021 and April 30, 2021, respectively. To the extent the Company generates sufficient taxable income in the future to utilize the tax benefits of the net deferred tax assets on which a valuation allowance is recorded, the effective tax rate may decrease as the valuation allowance is reversed.
Uncertain tax positions. The Company had no reserve for uncertain tax positions as of July 31, 2021 or April 30, 2021.

8. Stockholders’ Equity
The Company's Board of Directors has authorized a common stock repurchase program to repurchase up to $75.0 million of outstanding common stock. The Company may conduct repurchases under the share repurchase program through open market transactions, under trading plans in accordance with SEC Rule 10b5-1 and/or in privately negotiated transactions, in compliance with Rule 10b-18 under the Exchange Act of 1934, as amended. These repurchases are subject to a variety of factors, including, but not limited to, our liquidity, credit availability, general business and market conditions, our debt covenant
17

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

restrictions and the availability of alternative investment opportunities. The share repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion.
The Company repurchased approximately 85,000 shares of its common stock for $3.9 million during the three months ended July 31, 2021. The Company did not repurchase any shares of its common stock during the three months ended July 31, 2020. As of July 31, 2021, the Company had $50.5 million of remaining repurchase authorization under the stock repurchase program. 
Accumulated Other Comprehensive Income
The following table sets forth the changes to accumulated other comprehensive income (loss), net of tax, by component for the three months ended July 31, 2021:
Foreign
Currency
Translation
Derivative
Financial
Instruments
Accumulated
Other
Comprehensive
Income (Loss)
(in thousands)
Balance as of April 30, 2021 $ 20,764  $ (16,005) $ 4,759 
Other comprehensive loss before reclassification (8,233) (287) (8,520)
Reclassification to earnings from accumulated other comprehensive income (loss) 2,249  2,249 
Balance as of July 31, 2021 $ 12,531  $ (14,043) $ (1,512)
Other comprehensive loss on derivative instruments for the three months ended July 31, 2021 is net of $0.1 million of tax and reclassification to earnings from accumulated other comprehensive income (loss) is net of $0.7 million of tax.
9. Equity-Based Compensation
General
Equity-based compensation expense related to stock options and restricted stock units was $1.7 million and $1.4 million during the three months ended July 31, 2021 and 2020, respectively, and is included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income.
Stock Option Awards
The following table presents stock option activity for the three months ended July 31, 2021:
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (years)
Aggregate
Intrinsic
Value
(shares and dollars in thousands)
Outstanding as of April 30, 2021 1,289  $ 20.86  6.8 $ 29,465 
Options exercised (44) 19.75 
Options forfeited (3) 23.31 
Outstanding as of July 31, 2021 1,242  $ 20.89  6.5 $ 35,084 
Exercisable as of July 31, 2021 661  $ 18.90  5.0 $ 19,981 
Vested and Expected to vest as of July 31, 2021 1,239  $ 20.89  6.5 $ 34,992 
The aggregate intrinsic value represents the excess of the Company’s closing stock price on the last trading day of the period over the weighted average exercise price multiplied by the number of options outstanding, exercisable or expected to vest. Options expected to vest are unvested shares net of expected forfeitures. The total intrinsic value of options exercised during the three months ended July 31, 2021 and 2020 was $1.2 million and $0.3 million, respectively. As of July 31, 2021, there was $3.2 million of total unrecognized compensation cost related to stock options. That cost is expected to be recognized
18

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

over a weighted-average period of 1.6 years. There were no stock options granted during the three months ended July 31, 2021 or 2020.

Restricted Stock Units
The following table presents restricted stock unit activity for the three months ended July 31, 2021:
Number of
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
(shares in thousands)
Outstanding as of April 30, 2021 361  $ 22.92 
Vested (14) 18.04 
Forfeited (2) 23.21 
Outstanding as of July 31, 2021 345  $ 23.11 
As of July 31, 2021, there was $3.2 million of total unrecognized compensation cost related to nonvested restricted stock units. That cost is expected to be recognized over a weighted-average period of 1.6 years.
Employee Stock Purchase Plan
The Company has an employee stock purchase plan (“ESPP”), the terms of which allow for qualified employees to participate in the purchase of shares of the Company’s common stock at a price equal to 90% of the lower of the closing price at the beginning or end of the purchase period, which is a six-month period ending on December 31 and June 30 of each year. During the three months ended July 31, 2021, 43,000 shares of the Company’s common stock were purchased under the ESPP at a price of $26.36 per share. During the three months ended July 31, 2020, 58,000 shares of the Company’s common stock were purchased under the ESPP at a price of $22.13 per share. The Company recognized $0.2 million and $0.2 million of stock-based compensation expense during the three months ended July 31, 2021 and 2020, respectively, related to the ESPP.
10. Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests:
Stock
Appreciation
Rights
Deferred
Compensation
Redeemable
Noncontrolling
Interests
(in thousands)
Balance as of April 30, 2021 $ 26,795  $ 1,875  $ 9,373 
Amounts redeemed — 
Change in fair value 892  51  259 
Balance as of July 31, 2021 $ 27,687  $ 1,926  $ 9,632 
Classified as current as of April 30, 2021 $ 1,305  $ —  $ — 
Classified as long-term as of April 30, 2021 25,490  1,875  9,373 
Classified as current as of July 31, 2021 $ 1,521  $ —  $ — 
Classified as long-term as of July 31, 2021 26,166  1,926  9,632 
Total expense related to these instruments was $1.2 million and $1.0 million during the three months ended July 31, 2021 and 2020, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income. Current and long-term liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests are included in other accrued expenses and liabilities and other liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 13, "Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests," in the Company's Annual Report on Form 10-K for the year ended
19

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

April 30, 2021 for more information regarding stock appreciation rights, deferred compensation and redeemable noncontrolling interests.
11. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the estimated carrying amount and fair value of the Company’s liabilities measured at fair value on a recurring basis:
July 31,
2021
April 30,
2021
(in thousands)
Interest rate swaps (Level 2) $ 18,405  $ 21,004 
The Company has interest rate swap agreements with a notional amount of $500.0 million to convert the variable interest rate on a portion of its Term Loan Facility to a fixed 1-month LIBOR interest rate of 2.46%. The contracts were effective on February 28, 2019 and terminate on February 28, 2023. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with variable interest rates. The Company believes there have been no material changes in the creditworthiness of the counterparty to this interest rate swap and believes the risk of nonperformance by such party is minimal. The Company designated the interest rate swaps as a cash flow hedges.
As of July 31, 2021, $11.9 million of the interest rate swap liability was classified in other accrued expenses and current liabilities and $6.5 million was classified in other liabilities in the Condensed Consolidated Balance Sheet. The Company recognized losses, net of tax, of $2.2 million and $2.1 million in earnings during the three months ended July 31, 2021 and 2020, respectively, related to its interest rate swaps. These losses are included in interest expense in the Condensed Consolidated Statements of Operations and Comprehensive Income and within cash flows from operating activities within the Condensed Consolidated Statements of Cash Flows. As of July 31, 2021, the Company expects that approximately $11.9 million of pre-tax net losses will be reclassified from accumulated other comprehensive income (loss) into earnings during the next twelve months.
The fair value of interest rate swaps is determined using Level 2 inputs. Generally, the Company obtains the Level 2 inputs from its counterparties. Substantially all of the inputs throughout the full term of the instruments can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. The fair value of the Company’s interest rate swap was determined using widely accepted valuation techniques including a discounted cash flow analysis on the expected cash flows of the derivative. This analysis reflected the contractual terms of the derivatives, including the period to maturity, and used observable market-based inputs, including interest rate curves and implied volatilities.
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
Disclosures are required for certain assets and liabilities that are measured at fair value on a nonrecurring basis in periods subsequent to initial recognition. Such measurements of fair value relate primarily to assets and liabilities measured at fair value in connection with business combinations and long-lived asset impairments. For more information on business combinations, see Note 2, “Business Combinations.” There were no material long-lived asset impairments during the three months ended July 31, 2021 or 2020.
20

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

Fair Value of Debt
The estimated fair value of the Company’s Senior Notes was determined based on Level 2 input using observable market prices in less active markets. The carrying amount of the Company’s Term Loan Facility and ABL Facility approximates its fair value as the interest rates are variable and reflective of market rates. The following table presents the carrying value and fair value of the Company’s Senior Notes:
July 31, 2021 April 30, 2021
Carrying Amount Fair Value Carrying Amount Fair Value
(in thousands)
Senior Notes $ 350,000  $ 355,250  $ 350,000  $ 350,000 

12. Commitments and Contingencies
General
The Company is a defendant in various lawsuits and administrative actions associated with personal injuries, property damage, product liability claims, claims of former employees and other events arising in the normal course of business. As discussed in Note 1 “—Insurance Liabilities”, the Company records liabilities for these claims, and assets for amounts recoverable from the insurer, for claims covered by insurance.

13. Segments
There have been no changes to the Company's reportable segments during the three months ended July 31, 2021. For more information regarding the Company's reportable segments, see Note 17, "Segments," in the Company's Annual Report on Form 10-K for the year ended April 30, 2021.
Segment Results
The following tables present segment results:
Three Months Ended July 31, 2021
Net Sales Gross Profit Depreciation and
Amortization
Adjusted
EBITDA
(in thousands)
Geographic divisions $ 1,032,388  $ 332,685  $ 27,428  $ 127,017 
Other 9,688  3,148  88  1,062 
Corporate 198 
$ 1,042,076  $ 335,833  $ 27,714  $ 128,079 
Three Months Ended July 31, 2020
Net Sales Gross Profit Depreciation and
Amortization
Adjusted
EBITDA
(in thousands)
Geographic divisions $ 794,472  $ 257,838  $ 26,782  $ 82,503 
Other 8,101  2,620  91  551 
Corporate 224 
$ 802,573  $ 260,458  $ 27,097  $ 83,054 
21

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

The following table presents a reconciliation of Adjusted EBITDA to net income:
Three Months Ended
July 31,
2021 2020
(in thousands)
Net income $ 61,202  $ 27,219 
Interest expense 13,657  14,081 
Interest income —  (37)
Provision for income taxes 19,971  9,604 
Depreciation expense 12,925  12,827 
Amortization expense 14,789  14,270 
Stock appreciation rights(a) 892  792 
Redeemable noncontrolling interests(b) 310  252 
Equity-based compensation(c) 1,958  1,605 
Severance and other permitted costs(d) 147  1,947 
Transaction costs (acquisitions and other)(e) 575  100 
(Gain) loss on disposal and impairment of assets(f) (78) 394 
Effects of fair value adjustments to inventory(g) 1,731  — 
Adjusted EBITDA $ 128,079  $ 83,054 
__________________________________________

(a)Represents changes in the fair value of stock appreciation rights.
(b)Represents changes in the fair values of noncontrolling interests.
(c)Represents non-cash equity-based compensation expense related to the issuance of share-based awards.
(d)Represents severance expenses and other costs permitted in the calculation of Adjusted EBITDA under the ABL Facility and the Term Loan Facility, including certain unusual, nonrecurring costs and credits due to COVID-19.
(e)Represents costs related to acquisitions paid to third parties.
(f)Includes gains from the sale of assets and impairment of assets resulting from restructuring plans to close certain facilities.
(g)Represents the non-cash cost of sales impact of acquisition accounting adjustments to increase inventory to its estimated fair value.

Revenues by Product
The following table presents the Company’s net sales to external customers by main product lines:
Three Months Ended
July 31,
2021 2020
(in thousands)
Wallboard $ 390,135  $ 328,085 
Ceilings 138,071  114,643 
Steel framing 196,276  110,532 
Complementary products 317,594  249,313 
Total net sales $ 1,042,076  $ 802,573 
22

GMS Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)

Geographic Information
The following table presents the Company’s net sales by major geographic area:
Three Months Ended
July 31,
2021 2020
(in thousands)
United States $ 862,790  $ 679,321 
Canada 179,286  123,252 
Total net sales $ 1,042,076  $ 802,573 
The following table presents the Company’s property and equipment, net, by major geographic area:
July 31,
2021
April 30,
2021
(in thousands)
United States $ 284,177  $ 271,346 
Canada 39,790  39,980 
Total property and equipment, net $ 323,967  $ 311,326 

14. Earnings Per Common Share
The following table sets forth the computation of basic and diluted earnings per share of common stock:
Three Months Ended
July 31,
2021 2020
Net income $ 61,202  $ 27,219 
Basic earnings per common share:
Basic weighted average common shares outstanding 43,089  42,624 
Basic earnings per common share $ 1.42  $ 0.64 
Diluted earnings per common share:
Basic weighted average common shares outstanding 43,089  42,624 
Add: Common Stock Equivalents 883  393 
Diluted weighted average common shares outstanding 43,972  43,017 
Diluted earnings per common share $ 1.39  $ 0.63 
During the three months ended July 31, 2021, no Common Stock Equivalents were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive. Anti-dilutive securities could be dilutive in future periods.
15. Subsequent Event
On August 1, 2021, the Company acquired certain assets of DK&B Construction Specialties, Inc., Inc. (“DK&B”). DK&B is a distributor of External Insulation and Finishing Systems (EIFS) and stucco products through one location in Omaha, Nebraska.
23


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following information should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q. The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those factors discussed below and elsewhere in this Quarterly Report on Form 10-Q, particularly in “Cautionary Note Regarding Forward-Looking Statements,” and discussed in the section entitled “Risk Factors” included in our Annual Report on Form 10-K for the year ended April 30, 2021.
Overview
Founded in 1971, GMS Inc. (“we,” “our,” “us” or the “Company”) is a distributor of specialty building products including wallboard, suspended ceilings systems, or ceilings, steel framing and other complementary specialty building products. We purchase products from many manufacturers and then distribute these goods to a customer base consisting of wallboard and ceilings contractors and homebuilders and, to a lesser extent, general contractors and individuals. We operate a network of more than 280 distribution centers across the United States and Canada.
Business Strategy
Our business strategy includes an emphasis on organic growth through expanding market share in our core products (wallboard, ceilings and steel framing) and growing our complementary product lines (insulation, lumber, ready-mix joint compound, tools, fasteners and various other construction products). Our growth strategy also includes the pursuit of greenfield branch openings and strategic acquisitions as we seek to further broaden our geographic platform. We expect to continue to capture profitable market share in our existing footprint by delivering industry-leading customer service. Our strategy for opening new branches is to further penetrate markets that are adjacent to our existing operations. Typically, we have pre-existing customer relationships in these markets but need a new location to fully capitalize on those relationships. In addition, we will continue to pursue acquisitions. Due to the large, highly-fragmented nature of our markets and our reputation throughout the industry, we believe we have the potential to access a robust acquisition pipeline that will continue to supplement our organic growth. We use a rigorous targeting process to identify acquisition candidates that we believe will fit our culture and business model and we have built an experienced team of professionals to manage the acquisition and integration processes. As a result of our scale, purchasing power and ability to improve operations through implementing best practices, we believe we can continue to achieve substantial synergies and drive earnings accretion from our acquisition strategy. Finally, our growth strategy also entails a heightened focus on enhanced productivity and profitability across the organization, seeking to leverage our scale and employ both technology and other best practices to deliver further margin expansion and earnings growth.

COVID-19 Update

We continue to monitor the COVID-19 pandemic ("COVID-19") and its impact on macroeconomic and local economic conditions. We will continue to implement, as deemed necessary or advisable, procedures and processes to protect the health and safety of our employees, customers, partners and suppliers.

We may take further actions that alter our business operations if required by federal, state, provincial or local authorities or that we determine are in the best interests of our employees, customers, suppliers and stockholders. Furthermore, while COVID-19 had a limited impact on our financial results and operations during the three months ended July 31, 2021, there is no guarantee that COVID-19 will not have a material impact on our future financial results or operations. See Item 1A, “Risk Factors,” and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 for a discussion of risks which could have a material adverse effect on our operations and financial results and for more information regarding the impact of COVID-19 and our response.


24


Highlights

    Key highlights in our business during the three months ended July 31, 2021 are described below:

Generated net sales of $1,042.1 million during the three months ended July 31, 2021, a 29.8% increase from the prior year period primarily due to continued strength in the residential market, price inflation in the current year period and the negative impacts of COVID-19 in the prior year period.

Generated net income of $61.2 million during the three months ended July 31, 2021, a 124.9% increase compared to the prior year primarily due to the increase in net sales as noted above, partially offset by an increase in the provision for income taxes.

Generated Adjusted EBITDA (a non-GAAP measure, see “Non-GAAP Financial Measures” in this Item 2) of $128.1 million during the three months ended July 31, 2021, a 54.2% increase compared to the prior year primarily due to the increase in net sales noted above. Adjusted EBITDA as a percentage of net sales increased to 12.3% for the three months ended July 31, 2021 compared to 10.3% for the three months ended July 31, 2020 primarily due to better operating leverage, as product price inflation on sales outpaced operating cost inflation.

Recent Developments
Acquisitions

On July 1, 2021, we acquired substantially all the assets of Westside Building Material ("Westside"), one of the largest independent distributors of interior building products in the U.S., for preliminary consideration of $139.6 million. Westside is a leading supplier of steel framing, wallboard, acoustical ceilings, insulation and related building products serving commercial and residential markets. Westside’s distribution network comprises ten locations, including nine across California (Anaheim, Hesperia, Oakland, Chatsworth, Fresno, Lancaster, Santa Maria, San Diego and National City) and one in Las Vegas, Nevada. For more information regarding our acquisition of Westside, see Note 2 of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.
On June 3, 2021, we acquired the assets of Architectural Coatings Distributors, Inc. (“Architectural Coating”). Architectural Coating is an interior building products distributor in Cleveland, Ohio.
On August 1, 2021, we acquired certain assets of DK&B Construction Specialties, Inc., Inc. (“DK&B”). DK&B is a distributor of External Insulation and Finishing Systems (EIFS) and stucco products through one location in Omaha, Nebraska.

Greenfields

During the three months ended July 31, 2021, we opened five new greenfield locations. In May 2021, we opened a new greenfield location in Hickory, North Carolina. In June 2021, we opened a new greenfield location in Scarborough, Ontario. In July 2021, we opened greenfield locations in Denver, Colorado, Jackson, Mississippi and Wilmington, Delaware.

25


Results of Operations
The following table summarizes key components of our results of operations for the three months ended July 31, 2021 and 2020:
Three Months Ended
July 31,
2021 2020
(dollars in thousands)
Statement of operations data:      
Net sales $ 1,042,076  $ 802,573 
Cost of sales (exclusive of depreciation and amortization shown separately below) 706,243  542,115 
Gross profit 335,833  260,458 
Operating expenses:      
Selling, general and administrative expenses 214,081  183,112 
Depreciation and amortization 27,714  27,097 
Total operating expenses 241,795  210,209 
Operating income 94,038  50,249 
Other (expense) income:      
Interest expense (13,657) (14,081)
Other income, net 792  655 
Total other expense, net (12,865) (13,426)
Income before taxes 81,173  36,823 
Provision for income taxes 19,971  9,604 
Net income $ 61,202  $ 27,219 
Non-GAAP measures:      
Adjusted EBITDA(1) $ 128,079  $ 83,054 
Adjusted EBITDA margin(1)(2) 12.3  % 10.3  %
___________________________________

(1)Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. See “—Non-GAAP Financial Measures—Adjusted EBITDA,” for how we define and calculate Adjusted EBITDA and Adjusted EBITDA margin, reconciliations thereof to net income and a description of why we believe these measures are useful.

(2)Adjusted EBITDA margin is Adjusted EBITDA as a percentage of net sales.
Net Sales
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Wallboard $ 390,135  $ 328,085  $ 62,050  18.9  %
Ceilings 138,071  114,643  23,428  20.4  %
Steel framing 196,276  110,532  85,744  77.6  %
Complementary products 317,594  249,313  68,281  27.4  %
Total net sales $ 1,042,076  $ 802,573  $ 239,503  29.8  %
We generate net sales by providing a comprehensive product offering of wallboard, ceilings, steel framing and complementary construction products. The increase in net sales during the three months ended July 31, 2021 compared to the prior year period was primarily due to continued strength in the residential market, price inflation in the current year period, growth in complementary products sales and the negative impacts of COVID-19 in the prior year period. Also contributing to the increase were acquisitions and new greenfield openings over the past year. These increases were partially offset by one less
26


selling day during the three months ended July 31, 2021 compared to the prior year period. The increase consisted of the following:
an increase in wallboard sales, which are impacted by both commercial and residential construction activity, primarily due to an increase in price/product mix and higher volume;
an increase in ceilings sales, which is principally impacted by commercial construction activity, primarily due to an increase in price/product mix and higher volume;
an increase in steel framing sales, which is principally impacted by commercial construction activity, primarily due to an increase in price/product mix and higher volume; and
an increase in complementary products sales, which include insulation, joint treatment, tools, lumber and various other specialty building products, primarily due to an increase in pricing in certain product categories, the execution of growth initiatives to increase other products sales and positive contributions from acquisitions.
The following table breaks out our net sales into organic, or base business, net sales and recently acquired net sales for the three months ended July 31, 2021 and 2020. When calculating organic sales growth, we exclude the net sales of acquired businesses until the first anniversary of the acquisition date. In addition, we exclude the impact of foreign currency translation in our calculation of organic net sales growth.
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Net sales $ 1,042,076  $ 802,573 
Recently acquired net sales (1) (34,893) — 
Impact of foreign currency (2) (18,437) — 
Base business net sales (3) $ 988,746  $ 802,573  $ 186,173  23.2  %
___________________________________
(1)Represents net sales of branches acquired by us until the first anniversary of the acquisition date. For the three months ended July 31, 2021, this includes net sales of D. L. Building Materials, which was acquired on February 1, 2021, net sales of Architectural Coating, which was acquired on June 3, 2021, and net sales of Westside, which was acquired on July 1, 2021.
(2)Represents the impact of foreign currency translation on net sales.
(3)Represents net sales of existing branches and branches that were opened by us during the period presented.
The increase in organic net sales was primarily driven by continued strength in the residential market, price inflation in the current year period, growth in complementary products sales and the negative impacts of COVID-19 in the prior year period, partially offset by one less selling day during the current year period compared to the prior year period.
Gross Profit and Gross Margin
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Gross profit $ 335,833  $ 260,458  $ 75,375  28.9  %
Gross margin 32.2  % 32.5  %
The increase in gross profit during the three months ended July 31, 2021 compared to the prior year period was primarily due to continued strength in the residential market and the negative impacts of COVID-19 in the prior year period. The decrease in gross margin on net sales for the three months ended July 31, 2021 compared to the prior year period was primarily due to challenging price-cost dynamics for certain product categories. Included in cost of sales for the three months ended July 31, 2021 was a $1.7 million non-cash cost of sales charge to increase inventory acquired in the Westside acquisition to its estimated fair value. This adjustment had a negative effect on gross margin as the related inventory was sold.
27


Selling, General and Administrative Expenses
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Selling, general and administrative expenses $ 214,081  $ 183,112  $ 30,969  16.9  %
% of net sales 20.5  % 22.8  %
Selling, general and administrative expenses consist of warehouse, delivery and general and administrative expenses. Selling, general and administrative expenses increased during the three months ended July 31, 2021 compared to the prior year period primarily due to increases in payroll and payroll related costs, fuel costs, travel costs and facilities costs, which were driven by increased sales volume and organic growth. Selling, general and administrative expenses as a percent of our net sales decreased during the three months ended July 31, 2021 compared to the prior year period primarily due to the impact of inflationary market pricing on sales.
Depreciation and Amortization Expense
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Depreciation $ 12,925  $ 12,827  $ 98  0.8  %
Amortization 14,789  14,270  519  3.6  %
Depreciation and amortization $ 27,714  $ 27,097  $ 617  2.3  %
Depreciation and amortization expense includes depreciation of property and equipment and amortization of definite-lived intangible assets acquired in purchases of businesses. The increase in depreciation expense during the three months ended July 31, 2021 compared to the prior year period was primarily due to incremental expense resulting from property and equipment obtained in the acquisition of Westside, partially offset by assets becoming fully depreciated during the period. The increase in amortization expense during the three months ended July 31, 2021 was primarily due to incremental expense resulting from definite-lived intangible assets obtained in the acquisition of Westside and D.L. Building Materials, partially offset by time-based progression of our use of the accelerated method of amortization for acquired customer relationships.
Interest Expense
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Interest expense $ (13,657) $ (14,081) $ (424) (3.0) %
Interest expense consists primarily of interest expense incurred on our debt and finance leases and amortization of deferred financing fees and debt discounts. The decrease in interest expense during the three months ended July 31, 2021 compared to the prior year period was primarily due to a decrease in average debt outstanding during the comparable periods and a decrease in interest rates.
28


Income Taxes
Three Months Ended
July 31,
Change
2021 2020 Dollar Percent
(dollars in thousands)
Provision for income taxes $ 19,971  $ 9,604  $ 10,367  107.9  %
Effective tax rate 24.6  % 26.1  %
The change in the effective income tax rate during the three months ended July 31, 2021 compared to the prior year period was primarily due to the impact of state taxes, foreign taxes and a change in the valuation allowance in the prior year period.

Liquidity and Capital Resources
Summary
We depend on cash flow from operations, cash on hand and funds available under our asset based revolving credit facility (the “ABL Facility”) to finance working capital needs, capital expenditures and acquisitions. We believe that these sources of funds will be adequate to fund debt service requirements and provide cash, as required, to support our growth strategies, ongoing operations, capital expenditures, lease obligations and working capital for at least the next twelve months and in the long term. During fiscal 2021, we took several measures to preserve liquidity in response to COVID-19. We believe we would be able to take similar measures in the future should there be an economic downturn or disruption to our business as a result of the continuing COVID-19 pandemic or other factors.
As of July 31, 2021, we had available borrowing capacity of approximately $335.5 million under our $445.0 million ABL Facility. The ABL Facility is scheduled to mature on September 30, 2024.
As of July 31, 2021, we had available borrowing capacity of approximately $19.1 million under our Canadian revolving credit facility (the “Canadian Facility”) that provides for aggregate revolving commitments of $24.0 million ($30.0 million Canadian dollars). The Canadian Facility matures on January 12, 2026.
For more information regarding our ABL Facility and other indebtedness, see Note 5 of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q and Note 7 of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.
We have a common stock repurchase program authorized by our Board of Directors to repurchase up to $75.0 million of our outstanding common stock. The share repurchase program does not obligate us to acquire any particular amount of common stock, and it may be suspended or terminated at any time at our discretion. The timing and amount of any purchases of our common stock will be subject to a variety of factors, including, but not limited to, our liquidity, credit availability, general business and market conditions, our debt covenant restrictions and the availability of alternative investment opportunities. We repurchased approximately 85,000 shares of our common stock for $3.9 million during the three months ended July 31, 2021. As of July 31, 2021, we had $50.5 million of remaining purchase authorization. 
We regularly evaluate opportunities to optimize our capital structure, including through consideration of the issuance or incurrence of additional debt to refinance existing debt and to fund ongoing cash needs such as general corporate purposes, growth initiatives, acquisitions and our stock repurchase program.
29


Cash Flows
A summary of our operating, investing and financing activities is shown in the following table:
Three Months Ended July 31,
2021 2020
(in thousands)
Cash used in operating activities $ (75,077) $ (15,711)
Cash used in investing activities (129,576) (4,613)
Cash provided by (used in) financing activities 81,394  (51,819)
Effect of exchange rates on cash and cash equivalents (163) 943 
Decrease in cash and cash equivalents $ (123,422) $ (71,200)
Operating Activities
The increase in cash used in operating activities during the three months ended July 31, 2021 compared to the prior year period was primarily due to a $100.4 million decrease in cash resulting from changes in our net working capital, partially offset by a $41.0 million increase in net income after adjustments for non-cash items. The decrease in cash from net working capital was primarily due to an increase in inventory, as well as an increase in accounts receivable due to higher sales activity. In addition, in the prior year period we were still conserving cash in response to COVID-19.
Investing Activities
The increase in cash used in investing activities during the three months ended July 31, 2021 compared to the prior year period was primarily due to a $122.8 million increase in cash used for acquisitions and a $2.1 million increase in capital expenditures.
Capital expenditures during the three months ended July 31, 2021 primarily consisted of building and leasehold improvements, vehicles and IT-related spending. Capital expenditures vary depending on prevailing business factors, including current and anticipated market conditions. Historically, capital expenditures have remained at relatively low levels in comparison to the operating cash flows generated during the corresponding periods.
Financing Activities
The change in cash provided by (used in) financing activities during the three months ended July 31, 2021 compared to the prior year period was primarily due to net borrowings of $92.2 million of our revolving credit facilities during the three months ended July 31, 2021, compared to net repayments of $43.7 million during the prior year period. During the three months ended July 31, 2021, we used our revolvers to help fund the Westside acquisition and general working capital needs. During the prior year period, we repaid a portion of proceeds we proactively borrowed in March 2020 due to COVID-19. Also contributing to the change was $3.9 million of repurchases of common stock during the three months ended July 31, 2021. No shares were repurchased during the prior year period.
Debt Covenants
Our senior secured first lien term loan facility (the “Term Loan Facility”) contains a number of covenants that limit our ability and the ability of our restricted subsidiaries, as described in the respective credit agreement, to: incur more indebtedness; pay dividends, redeem or repurchase stock or make other distributions; make investments; create restrictions on the ability of our restricted subsidiaries to pay dividends to us or make other intercompany transfers; create liens securing indebtedness; transfer or sell assets; merge or consolidate; enter into certain transactions with our affiliates; and prepay or amend the terms of certain indebtedness. We were in compliance with all covenants contained in the Term Loan Facility as of July 31, 2021.
Our senior unsecured notes due May 2029 (the "Senior Notes") contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to incur additional indebtedness, make certain dividends, repurchase Company stock or make other distributions, make certain investments, create liens, transfer or sell assets, merge or consolidate, and enter into transactions with the Company’s affiliates. Such covenants are subject to a number of important exceptions and qualifications set forth in the related indenture. We were in compliance with all covenants contained in the Senior Notes as of July 31, 2021
30


The ABL Facility contains certain affirmative covenants, including financial and other reporting requirements. We were in compliance with all such covenants as of July 31, 2021.
Contractual Obligations
There have been no material changes to the contractual obligations as disclosed in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021, other than those made in the ordinary course of business.
Off-Balance Sheet Arrangements
There have been no material changes to our off-balance sheet arrangements as discussed in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.
Non-GAAP Financial Measures
Adjusted EBITDA
Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. We report our financial results in accordance with GAAP. However, we present Adjusted EBITDA and Adjusted EBITDA margin, which are not recognized financial measures under GAAP, because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes Adjusted EBITDA and Adjusted EBITDA margin are helpful in highlighting trends in our operating results, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure and allocation, the tax jurisdictions in which companies operate and capital investments and acquisitions.
In addition, we utilize Adjusted EBITDA in certain calculations under our debt agreements. Our debt agreements permit us to make certain additional adjustments in calculating Consolidated EBITDA, such as projected net cost savings, which are not reflected in the Adjusted EBITDA data presented in this Quarterly Report on Form 10-Q. We may in the future reflect such permitted adjustments in our calculations of Adjusted EBITDA.
We believe that Adjusted EBITDA and Adjusted EBITDA margin are frequently used by analysts, investors and other interested parties in their evaluation of companies, many of which present an Adjusted EBITDA or Adjusted EBITDA margin measure when reporting their results. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. In addition, Adjusted EBITDA may not be comparable to similarly titled measures used by other companies in our industry or across different industries.
We also include information concerning Adjusted EBITDA margin, which is calculated as Adjusted EBITDA divided by net sales. We present Adjusted EBITDA margin because it is used by management as a performance measure to judge the level of Adjusted EBITDA that is generated from net sales.
Adjusted EBITDA and Adjusted EBITDA margin have their limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP.
31


The following is a reconciliation of our net income to Adjusted EBITDA and Adjusted EBITDA margin:
Three Months Ended
July 31,
2021 2020
(in thousands)
Net income $ 61,202  $ 27,219 
Interest expense 13,657  14,081 
Interest income —  (37)
Provision for income taxes 19,971  9,604 
Depreciation expense 12,925  12,827 
Amortization expense 14,789  14,270 
Stock appreciation rights(a) 892  792 
Redeemable noncontrolling interests(b) 310  252 
Equity-based compensation(c) 1,958  1,605 
Severance and other permitted costs(d) 147  1,947 
Transaction costs (acquisitions and other)(e) 575  100 
(Gain) loss on disposal and impairment of assets(f) (78) 394 
Effects of fair value adjustments to inventory(g) 1,731  — 
Adjusted EBITDA $ 128,079  $ 83,054 
Net sales $ 1,042,076  $ 802,573 
Adjusted EBITDA Margin 12.3  % 10.3  %
___________________________________
(a)Represents changes in the fair value of stock appreciation rights.
(b)Represents changes in the fair values of noncontrolling interests.
(c)Represents non-cash equity-based compensation expense related to the issuance of share-based awards.
(d)Represents severance expenses and other costs permitted in the calculation of Adjusted EBITDA under the ABL Facility and the Term Loan Facility, including certain unusual, nonrecurring costs and credits due to COVID-19.
(e)Represents costs related to acquisitions paid to third parties.
(f)Includes gains from the sale of assets and impairment of assets resulting from restructuring plans to close certain facilities.
(g)Represents the non-cash cost of sales impact of acquisition accounting adjustments to increase inventory to its estimated fair value.
32


Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes to our exposure to market risks from those reported in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
As of July 31, 2021, our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), which are designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of July 31, 2021, our disclosure controls and procedures were effective to ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the three months ended July 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting except that on July 1, 2021 the Company acquired Westside Building Material ("Westside"). As a result, the Company is currently integrating Westside’s operations into its overall system of internal control over financial reporting. Under the guidelines established by the Securities and Exchange Commission, companies are permitted to exclude acquisitions from their assessment of internal control over financial reporting during the first year of acquisition. Accordingly, we expect to exclude Westside from the assessment of internal control over financial reporting for fiscal 2022.
33


PART II – Other Information
Item 1. Legal Proceedings
From time to time, we are involved in lawsuits that are brought against us in the normal course of business. We are not currently a party to any legal proceedings that would be expected, either individually or in the aggregate, to have a material adverse effect on our business or financial condition. For additional information, see Note 12, “Commitments and Contingencies.”
The building materials industry has been subject to personal injury and property damage claims arising from alleged exposure to raw materials contained in building products as well as claims for incidents of catastrophic loss, such as building fires. As a distributor of building materials, we face an inherent risk of exposure to product liability claims in the event that the use of the products we have distributed in the past or may in the future distribute is alleged to have resulted in economic loss, personal injury or property damage or violated environmental, health or safety or other laws. Such product liability claims have included and may in the future include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. In particular, certain of our subsidiaries have been the subject of claims related to alleged exposure to asbestos-containing products they distributed prior to 1979. Since 2002 and as of July 31, 2021, approximately 1,025 asbestos-related personal injury lawsuits have been filed and we vigorously defend against them. Of these, 980 have been dismissed without any payment by us, 35 are pending and only 10 have been settled, which settlements have not materially impacted our financial condition or operating results. See “Risk Factors—Risks Relating to Our Business and Industry—We are exposed to product liability, warranty, casualty, construction defect, contract, tort, employment and other claims and legal proceedings related to our business, the products we distribute, the services we provide and services provided for us by third parties” listed in Part 1, Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.
Item 1A. Risk Factors
There have been no material changes in the risks facing the Company as described in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The number of shares repurchased and the average price paid per share for each month in the three months ended July 31, 2021 are as follows:
Total Number
of Shares
Repurchased
Average Price
Paid Per Share
Total Number of Shares
Repurchased as
Part of Publicly
Announced Program (1)
Approximate
Dollar Value that May
Yet be Purchased
Under the Program
(in thousands)
May 1 through May 31 8,583  $ 44.41  8,583  $ 53,939 
June 1 through June 30 20,081  42.88  20,081  53,078 
July 1 through July 31 56,371  46.36  56,371  50,465 
Total 85,035  85,035 
___________________________________
(1)On November 30, 2018, our Board of Directors authorized a common stock repurchase program to repurchase up to $75.0 million of our outstanding common stock. We may conduct repurchases under the share repurchase program through open market transactions, under trading plans in accordance with Rule 10b5-1 and/or in privately negotiated transactions, in compliance with Rule 10b-18 under the Exchange Act of 1934, as amended, subject to a variety of factors, including, but not limited to, our liquidity, credit availability, general business and market conditions, our debt covenant restrictions and the availability of alternative investment opportunities. The share repurchase program does not obligate us to acquire any particular amount of common stock, and it may be suspended or terminated at any time at our discretion.

34


Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable.
Item 5. Other Information
None.
35


Item 6. Exhibits
(a)Exhibits. The following exhibits are filed as part of this report:
Exhibit No.      Exhibit Description
3.1   
3.2   
4.1 
10.1 *
10.2 *
31.1 *
31.2 *
32.1 *
32.2 *
101 INS * Inline XBRL Instance Document – the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document.
101 SCH * Inline XBRL Taxonomy Extension Schema Document.
101 CAL * Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101 DEF * Inline XBRL Taxonomy Extension Definition Linkbase Document.
101 LAB * Inline XBRL Taxonomy Extension Label Linkbase Document.
101 PRE * Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104  Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

*     Filed herewith.
36


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
GMS INC.
Date: September 2, 2021 By: /s/ Scott M. Deakin
Scott M. Deakin
Chief Financial Officer
(Principal Financial Officer)
37
Exhibit 10.1

GMS INC. 2020 EQUITY INCENTIVE PLAN
NONSTATUTORY STOCK OPTION - NOTICE OF GRANT
        
GMS Inc. (the “Company”), a Delaware corporation, hereby grants to the Optionee set forth below (the “Optionee”) an option (the “Option”) to purchase the number of Shares of common stock of the Company (“Shares”) set forth below at the Option Price set forth below, pursuant to the terms and conditions of this Notice of Grant (the “Notice”), the Nonstatutory Stock Option Award Agreement attached hereto as Exhibit A (the “Award Agreement”), and the GMS Inc. 2020 Equity Incentive Plan (the “Plan”).

Date of Grant:    [●]
Name of Optionee:    [●]
Number of Shares
Subject to Option
:    [●] Shares
Option Price
(Price Per Share):    $[●]1 per Share
Expiration Date:    10 year anniversary of the Date of Grant.
Vesting:    The Option shall vest pursuant to the terms and conditions set forth in Section 3 of the Award Agreement.
Vesting Start Date:    [●]

The Option shall be subject to the execution and return of this Notice by the Optionee to the Company within 30 days of the date hereof (including by utilizing an electronic signature and/or web-based approval and notice process or any other process as may be authorized by the Company). This Option is a non-qualified stock option and is not intended by the parties hereto to be, and shall not be treated as, an “incentive stock option” within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended. Capitalized terms used but not defined herein shall have the meaning attributed to such terms in the Award Agreement or, if not defined therein, in the Plan, unless the context requires otherwise. By executing this Notice, the Optionee acknowledges that his or her agreement to the covenants set forth in Section 7 of the Award Agreement is a material inducement to the Company in granting this Award to the Optionee.

This Notice may be executed by facsimile or electronic means (including, without limitation, PDF) and in one or more counterparts, each of which shall be considered an original instrument, but all of which together shall constitute one and the same agreement, and shall become binding when one or more counterparts have been signed by each of the parties hereto and delivered to the other party hereto.

[Signature Page Follows]
1 Option Price to equal fair market value per Share on Date of Grant.



IN WITNESS WHEREOF, the parties hereto have executed this Notice of Grant as of the Date of Grant set forth above.

GMS INC.


By:    
Name:
Title:



OPTIONEE


By:        
Name:




[Signature Page to Notice of Grant for the GMS Inc. 2020 Equity Incentive Plan Nonqualified Stock Option]


Exhibit A

GMS INC.
2020 EQUITY INCENTIVE PLAN
NON-STATUTORY STOCK OPTION
AWARD AGREEMENT

THIS NONSTATUTORY STOCK OPTION AWARD AGREEMENT (the “Award Agreement”) is entered into by and among GMS Inc. (the “Company”) and the individual set forth on the signature page to that certain Notice of Grant (the “Notice”) to which this Award Agreement is attached. The terms and conditions of the Option granted hereby, to the extent not controlled by the terms and conditions contained in the Plan, shall be as set forth in the Notice and this Award Agreement. Capitalized terms used but not defined herein shall have the meaning attributed to such terms in the Notice or, if not defined therein, in the Plan, unless the context requires otherwise.

1.No Right to Continued Employee Status or Consultant Service

Nothing contained in this Award Agreement shall confer upon the Optionee the right to the continuation of his or her Employee status, or, in the case of a Consultant or Director, to the continuation of his or her service arrangement, or in either case to interfere with the right of the Company or any of its Subsidiaries or other affiliates to Terminate the Optionee.

2.Term of Option

As a general matter, the Option will expire on the Expiration Date set forth in the Notice and be deemed to have been forfeited by the Optionee. As provided below, the Optionee’s right to exercise the Option may expire prior to the Expiration Date if the Optionee Terminates, including in the event of the Optionee’s Retirement, Disability or death. This Award Agreement shall remain in effect until the Option has fully vested and been exercised or any unexercised portion thereof has been forfeited by the Optionee as provided in this Award Agreement. No portion of this Option shall be exercisable after the Expiration Date, or such earlier date as may be applicable, except as provided herein.

3.Vesting of Option2

[Option 1: Subject to the remainder of this Section 3, the Option will vest as to thirty-three and one third percent (33.33%) on each anniversary of the Vesting Start Date, such that the Option shall become fully (100%) vested as of the third anniversary of the Vesting Start Date, subject to the Optionee not having Terminated as of the applicable vesting date.]

2 2020 Plan requires vesting period of at least one year.



[Option 2: Subject to the remainder of this Section 3, the Option shall become fully (100%) vested upon first anniversary of the Vesting Start Date, subject to the Optionee not having Terminated prior to such anniversary.]

If the Optionee incurs a Termination by reason of his or her death or Disability, then the Option shall become fully-vested and exercisable as of the date of such Termination. Except as otherwise provided herein, if the Optionee Terminates for any reason, the portion of the Option that has not vested as of such date shall terminate upon such Termination and be deemed to have been forfeited by the Optionee without consideration.

4.Exercise

Prior to the Expiration Date and at any time prior to the Optionee’s Termination, the Optionee may exercise all or a portion of the Option, to the extent vested, by giving notice in the form, to the person, and using the administrative method and the exercise procedures established by the Committee from time to time (including any procedures utilizing an electronic signature and/or web-based approval and notice process), specifying the number of Shares to be acquired. The Optionee’s right to exercise the vested portion of the Option following the date that of the Optionee’s Termination will depend on the reason for such Termination, as described in Sections 5, 6 and 7 below.

The Optionee must pay to the Company at the time of exercise the amount of the Option Price for the number of Shares covered by the notice to exercise (“Aggregate Option Price”). The Aggregate Option Price for any Shares purchased pursuant to the exercise of an Option shall be paid in any or any combination of the following forms: (v) cash or its equivalent (e.g., a check); (w) by making arrangements through a registered broker-dealer pursuant to cashless exercise procedures established by the Committee from time to time; (x) if permitted by the Committee in its sole discretion, the transfer, either actually or by attestation, to the Company of Shares held by the Optionee , such transfer to be upon such terms and conditions as determined by the Committee; (y) in the form of other property as determined by the Committee in its sole discretion; or (z) through Share withholding as a result of which the number of Shares issued upon exercise of an Option would be reduced by a number of Shares having a Fair Market Value equal to the Aggregate Option Price. Any Shares transferred to the Company as payment of the Aggregate Option Price shall be valued at their Fair Market Value on the last business day preceding the date of exercise of such Option. If requested by the Committee, the Optionee shall deliver this Award Agreement to the Company, which shall endorse thereon a notation of such exercise and return such Award Agreement to the Optionee. No fractional Shares (or cash in lieu thereof) shall be issued upon exercise of an Option and the number of Shares that may be purchased upon exercise shall be rounded down to the nearest number of whole Shares.

5.Termination of Service

If the Optionee incurs a Termination for any reason, whether voluntarily or involuntarily, without Cause, other than as a result of the Optionee’s death, Disability or Retirement, then the portion of this Option that has previously vested but has not been exercised shall remain exercisable until,



and shall terminate upon, the first to occur of (a) the end of the day that is ninety (90) days following the date of the Optionee’s Termination or (b) the Expiration Date. If the Optionee incurs a Termination for Cause, then this Option and all rights attached hereto shall be forfeited and terminate immediately upon the effective date of such Termination for Cause.

6.Death or Disability of the Optionee

Upon the Optionee’s Termination by reason of death or Disability, the vested portion of the Option shall remain exercisable until, and shall terminate upon, the first to occur of (a) the end of the day that is one hundred and eighty (180) days after the date of the Optionee’s Termination for death or Disability, as applicable, or (b) the Expiration Date of the Option. Until such termination of the Option, the vested portion of the Option may, to the extent that this Option has not previously been exercised by the Optionee, be exercised by the Optionee in the case of his or her Disability, or, in the case of death, by the Optionee’s personal representative or the person entitled to the Optionee’s rights under this Award Agreement.

7.Retirement of the Optionee

(a)    If the Optionee Terminates as a result of the Optionee’s Retirement and the Optionee agrees to be bound by the restrictive covenants set forth in Exhibit B attached hereto (the “Restrictive Covenants”), then (i) the Optionee shall continue to vest in the portion of the Option that was not vested and exercisable as of the date of the Optionee’s Retirement for the [Option 1: three-year] [Option 2: one-year] period following Optionee’s Retirement as if the Optionee’s employment had not terminated, unless the Optionee violates any of the Restrictive Covenants; and (ii) the Option shall terminate upon the Expiration Date, unless the Optionee violates any of the Restrictive Covenants. If, in the sole discretion of the Company, the Optionee violates one of the Restrictive Covenants, then the Option, whether or not vested, shall be immediately forfeited and cancelled as of the date of such violation.

For purposes of this Award Agreement, “Retirement” shall mean the Optionee’s termination of employment following attainment of age 63 or following attainment of age 60 plus 5 years of service, whichever is the first to occur.

For the avoidance of doubt, the Restrictive Covenants are separate and apart from, and shall be in addition to, any restrictive covenants the Optionee may be subject to pursuant to another agreement or arrangement with the Company.

(b)    If the Optionee Terminates as a result of the Optionee’s Retirement and the Optionee does not agree to be bound by the Restrictive Covenants, then the portion of this Option that has previously vested but has not been exercised shall remain exercisable until, and shall terminate upon, the first to occur of (i) the end of the day that is ninety (90) days following the date of the Optionee’s Retirement or (ii) the Expiration Date.




8.Change in Control

(a)    If (i) a Change in Control occurs while Optionee is employed by, or otherwise providing services to, the Company or one of its Subsidiaries, and (ii) the Option is not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control in a manner approved by the Committee, then, as of the effective date of the Change in Control, the Option shall become immediately vested and exercisable.

(b)    If (i) a Change in Control occurs while Optionee is employed by, or otherwise providing services to, the Company or one of its Subsidiaries, (ii) the Option is assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control in a manner approved by the Committee, and (iii) within two (2) years after the effective date of the Change in Control, the Optionee’s employment or service is terminated by the Company or one of its Subsidiaries without Cause or, if applicable, the Optionee resigns for Good Reason (as defined herein), then as of Optionee’s Termination, the Option shall be immediately vested and exercisable. For purposes of this Award Agreement, “Good Reason” shall have the meaning, if any, assigned such term in the employment, severance or similar agreement, if any, between the Optionee and the Company or one of its Subsidiaries, provided, however that if there is no such employment, severance or similar agreement in which “Good Reason” is defined, then “Good Reason” as used herein shall not be operative and shall not apply to the Option.

9.Prohibited Activities

(a)No Sale or Transfer. Unless otherwise required by law, this Option shall not be (i) sold, transferred or otherwise disposed of, (ii) pledged or otherwise hypothecated or (iii) subject to attachment, execution or levy of any kind, other than by will or by the laws of descent or distribution; provided, however, that any transferred Option will be subject to all of the same terms and conditions as provided in the Plan and this Award Agreement and the Optionee’s estate or beneficiary appointed in accordance with the Plan will remain liable for any withholding tax that may be imposed by any federal, state or local tax authority.

(b)Right to Terminate Option and Recovery. The Optionee understands and agrees that the Company has granted this Option to the Optionee to reward the Optionee for the Optionee’s future efforts and loyalty to the Company and its affiliates by giving the Optionee the opportunity to participate in the potential future appreciation of the Company. Accordingly, if (a) the Optionee materially violates the Optionee’s obligations relating to the non-disclosure or non-use of confidential or proprietary information under any Restrictive Agreement to which the Optionee is a party, or (b) the Optionee materially breaches or violates the Optionee’s obligations relating to non-disparagement under any Restrictive Agreement to which the Optionee is a party, or (c) the Optionee engages in any activity prohibited by this Section 7 of this Award Agreement, or (d) the Optionee materially breaches or violates any non-solicitation obligations under any Restrictive Agreement to which the Optionee is a party, or (e) the Optionee breaches or violates any non-competition obligations under any Restrictive Agreement to which the Optionee is a party, or (f) the Optionee is convicted of a felony against the Company or any of its affiliates,



then, in addition to any other rights and remedies available to the Company, the Company shall be entitled, at its option, exercisable by written notice, to terminate the Option (including the vested portion of the Option), or any unexercised portion thereof, which shall be of no further force and effect. “Restrictive Agreement” shall mean any agreement between the Company or any Subsidiary and the Optionee (including any prior option agreement) that contains non-competition, non-solicitation, non-hire, non-disparagement, or confidentiality restrictions applicable to the Optionee.
(c)Other Remedies. The Optionee specifically acknowledges and agrees that its remedies under this Section 7 shall not prevent the Company or any Subsidiary from seeking injunctive or other equitable relief in connection with the Optionee’s breach of any Restrictive Agreement. In the event that the provisions of this Section 7 should ever be deemed to exceed the limitation provided by applicable law, then the Optionee and the Company agree that such provisions shall be reformed to set forth the maximum limitations permitted.

10.No Rights as Stockholder

The Optionee shall have no rights as a stockholder with respect to the Shares covered by any exercise of this Option until the effective date of issuance of the Shares and the entry of the Optionee’s name as a shareholder of record on the books of the Company following exercise of this Option.
11.Taxation Upon Exercise of Option; Tax Withholding; Parachute Tax Provisions

The Optionee understands that, upon exercise of this Option, the Optionee will recognize income, for Federal, state and local income tax purposes, as applicable, in an amount equal to the amount by which the Fair Market Value of the Shares, determined as of the date of exercise, exceeds the Option Price. The acceptance of the Shares by the Optionee shall constitute an agreement by the Optionee to report such income in accordance with then applicable law and to cooperate with Company and its subsidiaries in establishing the amount of such income and corresponding deduction to the Company and/or its subsidiaries for its income tax purposes.

The Optionee is responsible for all tax obligations that arise as a result of the exercise of this Option. The Company may withhold from any amount payable to the Optionee an amount sufficient to cover any Federal, state or local withholding taxes which may become required with respect to such exercise or take any other action it deems necessary to satisfy any income or other tax withholding requirements as a result of the exercise this Option. The Company shall have the right to require the payment of any such taxes and require that the Optionee, or the Optionee’s beneficiary, to furnish information deemed necessary by the Company to meet any tax reporting obligation as a condition to exercise or before the issuance of any Shares pursuant to this Option. The Optionee may pay his or her withholding tax obligation in connection with the exercise of the Option, by making (w) a cash payment to the Company, or (x) arrangements through a registered broker-dealer pursuant to cashless exercise procedures established by the Committee from time to time. In addition, the Committee, in its sole discretion, may allow the Optionee, to pay his or her withholding tax obligation in connection with the exercise of the



Option, by (y) having withheld a portion of the Shares then issuable to him or her upon exercise of the Option or (z) surrendering Shares, in each case having an aggregate Fair Market Value equal to the amount required to be withheld in accordance with applicable tax requirements, all in accordance with such procedures as the Committee approves.

    In connection with the grant of this Option, the parties wish to memorialize their agreement regarding the treatment of any potential golden parachute payments as set forth in Exhibit A attached hereto.

12.Securities Laws; Tolling of Exercise Period Expiration

(a)Upon the acquisition of any Shares pursuant to the exercise of the Option, the Optionee will make such written representations, warranties, and agreements as the Committee may reasonably request in order to comply with securities laws or with this Award Agreement. Optionee hereby agrees not to offer, sell or otherwise attempt to dispose of any Shares issued to the Optionee upon exercise of the Option in any way which would: (x) require the Company to file any registration statement with the Securities and Exchange Commission (or any similar filing under state law or the laws of any other county) or to amend or supplement any such filing or (y) violate or cause the Company to violate the Securities Act, Exchange Act, as amended, the rules and regulations promulgated thereunder, or any other Federal, state or local law, or the laws of any other country. The Company reserves the right to place restrictions on any Shares the Optionee may receive as a result of the exercise of the Option.

(b)Notwithstanding any provision contained in this Award Agreement or the Plan to the contrary,

(i)if, following the Optionee’s Termination, all or a portion of the exercise period applicable to the Option occurs during a time when the Optionee cannot exercise the Option without violating (w) an applicable Federal, state or local law, (x) the rules related to a blackout period declared by the Company, (y) any agreed to lock-up arrangement, or (z) other similar circumstance, in each case, the exercise period applicable to the Option will be tolled for the number of days that such prohibitions or restrictions apply, such that the exercise period will be extended by the same number of days as were subject to the prohibitions or restrictions; provided, however, that the exercise period may not be extended due to such tolling past the Expiration Date of the Option as set forth above; and

(ii)if the Expiration Date is set to occur during a time that the Optionee cannot exercise the Option without violating an applicable Federal, state or local law (and the Option has not previously been exercised or otherwise terminated), the exercise period will be tolled until such time as the violation would no longer apply; provided, however, that the exercise period applicable to the Option in this event will be fifteen (15) days from the date such potential violation is longer applicable.




13.Modification, Extension and Renewal of Options

This Award Agreement may not be modified, amended, terminated and no provision hereof may be waived in whole or in part except by a written agreement signed by the Company and the Optionee and no modification shall, without the consent of the Optionee, alter to the Optionee’s material detriment or materially impair any rights of the Optionee under this Award Agreement except to the extent permitted under the Plan.

14.Notices

Unless otherwise provided herein, any notices or other communication given or made pursuant to the Notice, this Award Agreement or the Plan shall be in writing and shall be deemed to have been duly given (i) as of the date delivered, if personally delivered (including receipted courier service) or overnight delivery service, with confirmation of receipt; (ii) on the date the delivering party receives confirmation, if delivered by facsimile to the number indicated or by email to the address indicated or through an electronic administrative system designated by the Company; (iii) one (1) business day after being sent by reputable commercial overnight delivery service courier, with confirmation of receipt; or (iv) three (3) business days after being mailed by registered or certified mail, return receipt requested, postage prepaid and addressed to the intended recipient as set forth below:
(a)If to the Company at the address below:

    GMS Inc.
100 Crescent Centre Parkway, Suite 800
Tucker, Georgia 30084
Phone: (800) 392-4619
Attention: General Counsel
    
(b)If to the Optionee, at the most recent address, facsimile number or email contained in the Company’s records.

15.Award Agreement Subject to Plan and Applicable Law

This Option is made pursuant to the Plan and shall be interpreted to comply therewith. A copy of the Plan is attached hereto. Any provision of this Option inconsistent with the Plan shall be considered void and replaced with the applicable provision of the Plan. The Plan shall control in the event there shall be any conflict between the Plan, the Notice, and this Award Agreement, and it shall control as to any matters not contained in this Award Agreement. The Committee shall have authority to make constructions of this Award Agreement, and to correct any defect or supply any omission or reconcile any inconsistency in this Award Agreement, and to prescribe rules and regulations relating to the administration of this Award and other Awards granted under the Plan.




This Option shall be governed by the laws of the State of Delaware, without regard to the conflicts of law principles thereof, and subject to the exclusive jurisdiction of the courts therein. The Optionee hereby consents to personal jurisdiction in any action brought in any court, federal or state, within the State of Delaware having subject matter jurisdiction in the matter.

16.Headings and Capitalized Terms

Unless otherwise provided herein, capitalized terms used herein that are defined in the Plan and not defined herein shall have the meanings set forth in the Plan. Headings are for convenience only and are not deemed to be part of this Award Agreement. Unless otherwise indicated, any reference to a Section herein is a reference to a Section of this Award Agreement.
17.Severability and Reformation

If any provision of this Award Agreement shall be determined by a court of law of competent jurisdiction to be unenforceable for any reason, such unenforceability shall not affect the enforceability of any of the remaining provisions hereof; and this Award Agreement, to the fullest extent lawful, shall be reformed and construed as if such unenforceable provision, or part thereof, had never been contained herein, and such provision or part thereof shall be reformed or construed so that it would be enforceable to the maximum extent legally possible.

18.Binding Effect

This Award Agreement shall be binding upon the parties hereto, together with their personal executors, administrator, successors, personal representatives, heirs and permitted assigns.

19.Entire Agreement

This Award Agreement, together with the Plan, supersedes all prior written and oral agreements and understandings among the parties as to its subject matter and constitutes the entire agreement of the parties with respect to the subject matter hereof. If there is any conflict between the Notice, this Award Agreement and the Plan, then the applicable terms of the Plan shall govern.
20.Waiver

Waiver by any party of any breach of this Award Agreement or failure to exercise any right hereunder shall not be deemed to be a waiver of any other breach or right whether or not of the same or a similar nature. The failure of any party to take action by reason of such breach or to exercise any such right shall not deprive the party of the right to take action at any time while or after such breach or condition giving rise to such rights continues.





Exhibit A

PARACHUTE TAX PROVISIONS

This Exhibit A sets forth the terms and provisions applicable to the Optionee pursuant to the provisions of Section 9 of the Award Agreement. This Exhibit A shall be subject in all respects to the terms and conditions of the Award Agreement.

(a)    To the extent that the Optionee, would otherwise be eligible to receive a payment or benefit pursuant to the terms of this Award Agreement, any employment or other agreement with the Company or any Subsidiary or otherwise in connection with, or arising out of, the Optionee’s employment with the Company or a change in ownership or effective control of the Company or of a substantial portion of its assets (any such payment or benefit, a “Parachute Payment”), that a nationally recognized United States public accounting firm selected by the Company (the “Accountants”) determines, but for this sentence would be subject to excise tax imposed by Section 4999 of the Code (the “Excise Tax”), subject to clause (c) below, then the Company shall pay to the Optionee whichever of the following two alternative forms of payment would result in the Optionee’s receipt, on an after-tax basis, of the greater amount of the Parachute Payment notwithstanding that all or some portion of the Parachute Payment may be subject to the Excise Tax: (1) payment in full of the entire amount of the Parachute Payment (a “Full Payment”), or (2) payment of only a part of the Parachute Payment so that the Optionee receives the largest payment possible without the imposition of the Excise Tax (a “Reduced Payment”).

(b)    If a reduction in the Parachute Payment is necessary pursuant to clause (a), then the reduction shall occur in the following order: (1) cancellation of acceleration of vesting on any equity awards for which the exercise price exceeds the then fair market value of the underlying equity; (2) reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they would otherwise be made, that is, later payments shall be reduced before earlier payments); and (3) cancellation of acceleration of vesting of equity awards not covered under (1) above; provided, however, that in the event that acceleration of vesting of equity awards is to be cancelled, acceleration of vesting of full value awards shall be cancelled before acceleration of options and stock appreciation rights and within each class such acceleration of vesting shall be cancelled in the reverse order of the date of grant of such equity awards, that is, later equity awards shall be canceled before earlier equity awards; and provided, further, that to the extent permitted by Code Section 409A and Sections 280G and 4999 of the Code, if a different reduction procedure would be permitted without violating Code Section 409A or losing the benefit of the reduction under Sections 280G and 4999 of the Code, the Optionee may designate a different order of reduction.

(c)    For purposes of determining whether any of the Parachute Payments (collectively the “Total Payments”) will be subject to the Excise Tax and the amount of such Excise Tax, (i) the Total Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base amount” (as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax,



unless and except to the extent that, in the opinion of the Accountants, such Total Payments (in whole or in part): (1) do not constitute “parachute payments,” including giving effect to the recalculation of stock options in accordance with Treasury Regulation Section 1.280G-1, Q&A 33, (2) represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the “base amount” or (3) are otherwise not subject to the Excise Tax, and (ii) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants in accordance with the principles of Section 280G of the Code.

(d)    All determinations hereunder shall be made by the Accountants, which determinations shall be final and binding upon the Company and the Optionee.

(e)    The federal tax returns filed by the Optionee (and any filing made by a consolidated tax group which includes the Company) shall be prepared and filed on a basis consistent with the determination of the Accountants with respect to the Excise Tax payable by the Optionee. The Optionee shall make proper payment of the amount of any Excise Tax, and at the request of the Company, provide to the Company true and correct copies (with any amendments) of his or her federal income tax return as filed with the Internal Revenue Service, and such other documents reasonably requested by the Company, evidencing such payment (provided that the Optionee may delete information unrelated to the Parachute Payment or Excise Tax and provided, further that the Company at all times shall treat such returns as confidential and use such return only for purpose contemplated by this paragraph).

(f)    In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the Optionee shall permit the Company to control issues related to the Excise Tax (at its expense), provided that such issues do not potentially materially adversely affect the Optionee but the Optionee shall control any other issues. In the event that the issues are interrelated, the Optionee and the Company shall in good faith cooperate so as not to jeopardize resolution of either issue. In the event of any conference with any taxing authority as to the Excise Tax or associated income taxes, the Optionee shall permit the representative of the Company to accompany the Optionee, and the Optionee and his representative shall cooperate with the Company and its representative.

(g)    The Company shall be responsible for all charges of the Accountants.

(h)    The Company and the Optionee shall promptly deliver to each other copies of any written communications, and summaries of any verbal communications, with any taxing authority regarding the Excise Tax covered by this Exhibit A.

(i)    Nothing in this Exhibit A is intended to violate the Sarbanes-Oxley Act of 2002 and to the extent that any advance or repayment obligation hereunder would do so, such obligation shall be modified so as to make the advance a nonrefundable payment to the Optionee and the repayment obligation null and void.




(j)    Notwithstanding the foregoing, any payment or reimbursement made pursuant to this Exhibit A shall be paid to the Optionee promptly and in no event later than the end of the calendar year next following the calendar year in which the related tax is paid by the Optionee or where no taxes are required to be remitted, the end of the Optionee’s calendar year following the Optionee’s calendar year in which the audit is completed or there is a final and nonappealable settlement or other resolution of the litigation.

(k)    The provisions of this Exhibit A shall survive the termination of the Optionee’s employment with the Company for any reason and the termination of the Award Agreement.





Exhibit B

RESTRICTIVE COVENANTS

This Exhibit B contains the Restrictive Covenants applicable to the Optionee if the Optionee agrees to be bound by the Restrictive Covenants as a condition to receipt of the benefits set forth in Section 7(a) of the Award Agreement.

1.    Unauthorized Disclosure. The Optionee agrees and understands that in the Optionee’s position with the Company, the Optionee has and shall be exposed to and has and shall receive information relating to the confidential affairs of the Company and its direct and indirect subsidiaries and affiliates (the “Company Group”), including, without limitation, technical information, intellectual property, business and marketing plans, strategies, customer information, software, other information concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company Group and other forms of information considered by the Company Group to be confidential or in the nature of trade secrets (including, without limitation, ideas, research and development, know-how, formulas, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and marketing plans and proposals) (collectively, the “Confidential Information”). Confidential Information shall not include information that is generally known to the public or within the relevant trade or industry other than due to the Optionee’s violation of this Section 1 of Exhibit B or disclosure by a third party who is known by the Optionee to owe the Company an obligation of confidentiality with respect to such information. The Optionee agrees that at all times during the Optionee’s employment with the Company and thereafter, the Optionee shall not disclose such Confidential Information, either directly or indirectly, to any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof (each a “Person”) without the prior written consent of the Company and shall not use or attempt to use any such information in any manner other than in connection with the Optionee’s employment with the Company, unless required by law to disclose such information, in which case the Optionee shall provide the Company with written notice of such requirement as far in advance of such anticipated disclosure as possible. This confidentiality covenant has no temporal, geographical or territorial restriction. The Optionee understands and acknowledges that nothing in this section limits the Optionee’s ability to report possible violations of federal, state, or local law or regulation to any governmental agency or entity; to communicate with any government agencies or otherwise participate in any investigation or proceeding that may be conducted by any government agencies in connection with any charge or complaint, whether filed by the Optionee, on the Optionee’s behalf, or by any other individual; or to make other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and the Optionee shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that the Optionee has made such reports or disclosures. In addition, and anything herein to the contrary notwithstanding, the Optionee is hereby given notice that the Optionee shall not be criminally or civilly liable under any federal or state trade secret law for disclosing a trade secret (as defined by 18 U.S.C. § 1839) in confidence to a federal, state, or



local government official, either directly or indirectly, or to an attorney, in either event solely for the purpose of reporting or investigating a suspected violation of law; or disclosing a trade secret (as defined by 18 U.S.C. § 1839) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
2.    Return of Property. Upon termination of the Optionee’s employment with the Company, the Optionee shall promptly supply to the Company all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data and any other tangible product or document which has been produced by, received by or otherwise submitted to the Optionee during or prior to the Optionee’s employment with the Company, and any copies thereof in the Optionee’s (or reasonably capable of being reduced to the Optionee’s) possession; provided that nothing in this Award Agreement or elsewhere shall prevent the Optionee from retaining and utilizing: documents relating to the Optionee’s personal benefits, entitlements and obligations; documents relating to the Optionee’s personal tax obligations; the Optionee’s desk calendar, rolodex, and the like; and such other records and documents as may reasonably be approved by the Company. To the extent that the Optionee has electronic files or information in the Optionee’s possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile devices, electronic media, or in cloud storage), on or prior to Optionee’s Termination, or at any other time the Company requests, the Optionee shall (i) provide the Company with an electronic copy of all of such files or information (in an electronic format that readily accessible by the Company); (ii) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and other media, devices, and equipment, such that such files and information are permanently deleted and irretrievable; and (iii) provide a written certification to the Company that the required deletions have been completed and specifying the files and information deleted and the media source from which they were deleted.
3.    Non-Competition. By and in consideration of the Company’s grant of the Option, and in further consideration of the Optionee’s exposure to the Confidential Information of the Company Group, the Optionee agrees that the Optionee shall not, during Optionee’s employment with the Company and for twelve (12) months following the Optionee’s Termination (the “Restriction Period”), directly or indirectly, own, manage, operate, join, control, be employed by, or participate in the ownership, management, operation or control of, or be connected in any manner with, including, without limitation, holding any position as a stockholder, director, officer, consultant, independent contractor, employee, partner, or investor in, any Restricted Enterprise (as defined below); provided, that in no event shall ownership of one percent or less of the outstanding securities of any class of any issuer whose securities are registered under the Securities Exchange Act of 1934, as amended, standing alone, be prohibited by this Section 3 of Exhibit B, so long as the Optionee does not have, or exercise, any rights to manage or operate the business of such issuer other than rights as a stockholder thereof. For purposes of this paragraph, “Restricted Enterprise” shall mean any Person that is actively engaged in any geographic area in which any member of the Company Group operates or markets in any business which is in material competition with the business of any member of the Company Group. During the



Restriction Period, upon request of the Company, the Optionee shall notify the Company of the Optionee’s then-current employment status.
4.    Non-Solicitation of Employees. During the Restriction Period, the Optionee shall not directly or indirectly contact, induce or solicit (or assist any Person to contact, induce or solicit) for employment any person who is, or within twelve (12) months prior to the date of such solicitation was, an employee of any member of the Company Group other than an employee (a) whose employment was involuntarily terminated by a member of the Company Group after the Optionee’s Termination and (b) who has not been an employee of the Company Group for six months or longer. The foregoing restriction shall not apply to the placement of general advertisements or other notices of employment opportunities that are not targeted, directly or indirectly, to any current or former employee of the Company otherwise covered by the scope of such restriction so long as the Optionee is not personally involved in the recruitment or hiring of any such employee subsequent to such general advertisement or other notice.
5.    Interference with Business Relationships. During the Restriction Period (other than in connection with carrying out the Optionee’s responsibilities for the Company Group), the Optionee shall not directly or indirectly induce or solicit (or assist any Person to induce or solicit) any customer or client of any member of the Company Group to terminate its relationship or otherwise cease doing business in whole or in part with any member of the Company Group, or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship between any member of the Company Group and any of their customers or clients so as to cause harm to any member of the Company Group.
6.    Extension of Restriction Period. The Restriction Period shall be tolled for any period during which the Optionee is in breach of any of Sections 3, 4 or 5 of this Exhibit B.
7.    Proprietary Rights. The Optionee shall disclose promptly to the Company any and all inventions, discoveries, and improvements (whether or not patentable or registrable under copyright or similar statutes), and all patentable or copyrightable works, initiated, conceived, discovered, reduced to practice, or made by the Optionee, either alone or in conjunction with others, during the Optionee’s employment with the Company and related to the business or activities of the Company Group (the “Developments”). Except to the extent any rights in any Developments constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq. that are owned ab initio by a member of the Company Group, the Optionee assigns and agrees to assign all of the Optionee’s right, title and interest in all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including all rights or benefits therefor, including without limitation the right to sue and recover for past and future infringement. The Optionee acknowledges that any rights in any Developments constituting a work made for hire under the U.S. Copyright Act, 17 U.S.C § 101 et seq. are owned upon creation by the Company as the Optionee’s employer. Whenever requested to do so by the Company, the Optionee shall execute any and all applications, assignments or other instruments which the Company shall deem necessary to apply for and obtain trademarks, patents or copyrights of the United States or any foreign country or otherwise protect the interests of the Company Group. These obligations shall continue beyond the end of



the Optionee’s employment with the Company with respect to inventions, discoveries, improvements or copyrightable works initiated, conceived or made by the Optionee while employed by the Company, and shall be binding upon the Optionee’s employers, assigns, executors, administrators and other legal representatives. If the Company is unable for any reason, after reasonable effort, to obtain the Optionee’s signature on any document needed in connection with the actions described in this Section 7 of Exhibit B, the Optionee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Optionee’s agent and attorney in fact to act for and on the Optionee’s behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of this Section 7 of Exhibit B with the same legal force and effect as if executed by the Optionee.
8.    Remedies. The Optionee agrees that any breach of the terms of the Restrictive Covenants contained in this Exhibit B would result in irreparable injury and damage to the Company Group for which the Company would have no adequate remedy at law; the Optionee therefore also agrees that in the event of said breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent such breach and/or threatened breach and/or continued breach by the Optionee and/or any and all Persons acting for and/or with the Optionee, without having to prove damages, in addition to any other remedies to which the Company may be entitled at law or in equity. The terms of this paragraph shall not prevent the Company from pursuing any other available remedies for any breach or threatened breach hereof, including, without limitation, the recovery of damages from the Optionee. The Optionee and the Company further agree that the provisions of the covenants contained in this Exhibit B are reasonable and necessary to protect the businesses of the Company Group because of the Optionee’s access to Confidential Information and the Optionee’s material participation in the operation of such businesses. In the event that the Optionee willfully and materially breaches any of the covenants set forth in this Exhibit B, then in addition to any injunctive relief, the Optionee shall forfeit the Option in its entirety, whether vested or unvested.
9.    Applicable Law; Forum Selection; Consent to Jurisdiction. The Company and the Optionee agree that, notwithstanding anything in this Award Agreement to the contrary, this Exhibit B shall be governed by and construed and interpreted in accordance with the laws of the State of Georgia without giving effect to its conflicts of law principles. The Optionee agrees that the exclusive forum for any action to enforce this Exhibit B, as well as any action relating to or arising out of this Exhibit B, shall be the federal and state courts of the State of Georgia. With respect to any such court action, the Optionee hereby irrevocably submits to the personal jurisdiction of such courts. The Company and the Optionee hereto further agree that the courts listed above are convenient forums for any dispute that may arise herefrom and that neither party shall raise as a defense that such courts are not convenient forums.
10.    Non-Disparagement. From and after the date of grant and following the Optionee’s Termination, the Optionee agrees not to make any statement, whether direct or indirect, whether true or false, that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory of the Company, any of its subsidiaries, affiliates, employees, officers, directors or stockholders. This Section 10 of



Exhibit B shall not in any way limit any of the protected rights contained in the last two sentences of Section 1 of Exhibit B of this Award Agreement, or the Optionee’s ability to provide truthful testimony pursuant to a subpoena, court order or as otherwise required by law.
11.    Survival. The obligations of the Optionee under this Exhibit B shall survive the termination of this Award Agreement and the Optionee’s Termination for the periods expressly designated in this Exhibit B or, if no such period is designated, for the maximum period permissible under applicable law.


Exhibit 10.2

GMS INC. 2020 EQUITY INCENTIVE PLAN
RESTRICTED STOCK UNIT - NOTICE OF GRANT

GMS Inc. (the “Company”), a Delaware corporation, hereby grants to the Grantee set forth below (the “Grantee”) Restricted Stock Units (the “Restricted Stock Units”), pursuant to the terms and conditions of this Notice of Grant (the “Notice”), the Restricted Stock Unit Award Agreement attached hereto as Exhibit A (the “Award Agreement”), and the GMS Inc. 2020 Equity Incentive Plan (the “Plan”). Capitalized terms used but not defined herein shall have the meaning attributed to such terms in the Award Agreement or, if not defined therein, in the Plan, unless the context requires otherwise. Each Restricted Stock Unit represents the right to receive one (1) Share at the time and in the manner set forth in Section 4 of the Award Agreement.

Date of Grant:    [●]

Name of Grantee:    [●]

Number of
Restricted Stock Units
:    [●] Shares

Vesting:    The Restricted Stock Units shall vest pursuant to the terms and conditions set forth in Section 3 of the Award Agreement.
Vesting
Start Date     [●]

The Restricted Stock Units shall be subject to the execution and return of this Notice by the Grantee to the Company within 30 days of the date hereof (including by utilizing an electronic signature and/or web-based approval and notice process or any other process as may be authorized by the Company). By executing this Notice, the Grantee acknowledges that his or her agreement to the covenants set forth in Section 8 of the Award Agreement is a material inducement to the Company in granting this Award to the Grantee.

This Notice may be executed by facsimile or electronic means (including, without limitation, PDF) and in one or more counterparts, each of which shall be considered an original instrument, but all of which together shall constitute one and the same agreement, and shall become binding when one or more counterparts have been signed by each of the parties hereto and delivered to the other party hereto.

[Signature Page Follows]



IN WITNESS WHEREOF, the parties hereto have executed this Notice of Grant as of the Date of Grant set forth above.

GMS INC.


By:    
Name:
Title:



GRANTEE


By:        
Name: [●]



[Signature Page to Notice of Restricted Stock Unit Grant for the GMS Inc. 2020 Equity Incentive Plan]


Exhibit A

GMS INC.
2020 EQUITY INCENTIVE PLAN
RESTRICTED STOCK UNIT
AWARD AGREEMENT

THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Award Agreement”) is entered into by and among GMS Inc. (the “Company”) and the individual set forth on the signature page to that certain Notice of Grant (the “Notice”) to which this Award Agreement is attached. The terms and conditions of the Restricted Stock Units granted hereby, to the extent not controlled by the terms and conditions contained in the Plan, shall be as set forth in the Notice and this Award Agreement. Capitalized terms used but not defined herein shall have the meaning attributed to such terms in the Notice or, if not defined therein, in the Plan, unless the context requires otherwise.

1.No Right to Continued Employee Status or Consultant Service

Nothing contained in this Award Agreement shall confer upon the Grantee the right to the continuation of his or her Employee status, or, in the case of a Consultant or Director, to the continuation of his or her service arrangement, or in either case to interfere with the right of the Company or any of its Subsidiaries or other affiliates to Terminate the Grantee.

2.Term of Restricted Stock Units

This Award Agreement shall remain in effect until the Restricted Stock Units have fully vested and been settled or been forfeited by the Grantee as provided in this Award Agreement.

3.Vesting of Restricted Stock Units.1

[Option 1: Subject to the remainder of this Section 3, the Restricted Stock Units will vest as to thirty three and one third percent (33.3%) on each anniversary of the Vesting Start Date, such that the Restricted Stock Units shall become fully (100%) vested as of the third anniversary of the Vesting Start Date, subject to the Grantee not having Terminated as of the applicable vesting date.]

[Option 2: Subject to the remainder of this Section 3, the Restricted Stock Units shall become fully (100%) vested upon first anniversary of the Vesting Start Date, subject to the Grantee not having Terminated prior to such anniversary.]

Except as otherwise provided herein, if the Grantee Terminates for any reason, the portion of the Restricted Stock Units that has not vested as of such date shall terminate upon such Termination and be deemed to have been forfeited by the Grantee without consideration.
1 2020 Plan requires vesting period of at least one year.




4.Settlement

Within thirty (30) days following the date on which any portion of the Restricted Stock Units vest pursuant to Section 3 of this Award Agreement (or Section 5, 6 or 7 of this Award Agreement, if applicable), the Company shall deliver to the Grantee one (1) Share in settlement of each Restricted Stock Unit that becomes vested on such vesting date.
5.Termination of Service

Except as otherwise provided herein, if the Grantee incurs a Termination for any reason, whether voluntarily or involuntarily, then the portion of the Restricted Stock Units that have not previously vested shall terminate as of the date of the Grantee’s Termination and be deemed to have been forfeited by the Grantee without consideration. If the Grantee incurs a Termination by reason of his or her death or Disability, then the Restricted Stock Units shall be immediately vested as of the date of such Termination. If the Grantee incurs a Termination for Cause, then the Restricted Stock Units (whether or not vested) shall be forfeited and terminate immediately without consideration upon the effective date of such Termination for Cause.

6.Retirement of the Grantee

(a)    If the Grantee Terminates as a result of the Grantee’s Retirement and the Grantee agrees to be bound by the restrictive covenants set forth in Exhibit B attached hereto (the “Restrictive Covenants”), then the Grantee shall continue to vest in the portion of the Restricted Stock Units that were not vested as of the date of the Grantee’s Retirement for the [Option 1: three-year] [Option 2: one-year] period following Grantee’s Retirement as if the Grantee’s employment had not terminated, unless the Grantee violates any of the Restrictive Covenants. If, in the sole discretion of the Company, the Grantee violates one of the Restrictive Covenants, then the Restricted Stock Units shall be immediately forfeited and cancelled as of the date of such violation.

For purposes of this Award Agreement, “Retirement” shall mean the Grantee’s termination of employment following attainment of age 63 or following attainment of age 60 plus 5 years of service, whichever is the first to occur.

For the avoidance of doubt, the Restrictive Covenants are separate and apart from, and shall be in addition to, any restrictive covenants the Grantee may be subject to pursuant to another agreement or arrangement with the Company.

(b)    If the Grantee Terminates as a result of the Grantee’s Retirement and the Grantee does not agree to be bound by the Restrictive Covenants, then the portion of the Restricted Stock Units that have not previously vested shall terminate as of the date of the Grantee’s Termination and be deemed to have been forfeited by the Grantee without consideration.




7.Change in Control

(a)    If (i) a Change in Control occurs while Grantee is employed by, or otherwise providing services to, the Company or one of its Subsidiaries, and (ii) the Restricted Stock Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control in a manner approved by the Committee, then, as of the effective date of the Change in Control, the Restricted Stock Units shall become immediately vested.

(b)    If (i) a Change in Control occurs while Grantee is employed by, or otherwise providing services to, the Company or one of its Subsidiaries, (ii) the Restricted Stock Units are assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control in a manner approved by the Committee, and (iii) within two (2) years after the effective date of the Change in Control, the Grantee’s employment or service is terminated by the Company or one of its Subsidiaries without Cause or, if applicable, the Grantee resigns for Good Reason (as defined herein), then as of Grantee’s Termination, the Restricted Stock Units shall be immediately vested. For purposes of this Award Agreement, “Good Reason” shall have the meaning, if any, assigned such term in the employment, severance or similar agreement, if any, between the Grantee and the Company or one of its Subsidiaries, provided, however, that if there is no such employment, severance or similar agreement in which “Good Reason” is defined, then “Good Reason” as used herein shall not be operative and shall not apply to the Restricted Stock Units.

8.Prohibited Activities

(a)No Sale or Transfer. Unless otherwise required by law, the Restricted Stock Units shall not be (i) sold, transferred or otherwise disposed of, (ii) pledged or otherwise hypothecated or (iii) subject to attachment, execution or levy of any kind, other than by will or by the laws of descent or distribution; provided, however, that any transferred Restricted Stock Units will be subject to all of the same terms and conditions as provided in the Plan and this Award Agreement and the Grantee’s estate or beneficiary appointed in accordance with the Plan will remain liable for any withholding tax that may be imposed by any federal, state or local tax authority.

(b)Right to Terminate Restricted Stock Units and Recovery. The Grantee understands and agrees that the Company has granted the Restricted Stock Units to the Grantee to reward the Grantee for the Grantee’s future efforts and loyalty to the Company and its affiliates by giving the Grantee the opportunity to participate in the potential future appreciation of the Company. Accordingly, if (a) the Grantee materially violates the Grantee’s obligations relating to the non-disclosure or non-use of confidential or proprietary information under any Restrictive Agreement to which the Grantee is a party, or (b) the Grantee materially breaches or violates the Grantee’s obligations relating to non-disparagement under any Restrictive Agreement to which the Grantee is a party, or (c) the Grantee engages in any activity prohibited by this Section 8 of this Award Agreement, or (d) the Grantee materially breaches or violates any non-solicitation obligations under any Restrictive Agreement to which the Grantee is a party, or



(e) the Grantee breaches or violates any non-competition obligations under any Restrictive Agreement to which the Grantee is a party, or (f) the Grantee is convicted of a felony against the Company or any of its affiliates, then, in addition to any other rights and remedies available to the Company, the Company shall be entitled, at its option, exercisable by written notice, to terminate the Restricted Stock Units (including the vested portion of the Restricted Stock Units) without consideration, which shall be of no further force and effect. “Restrictive Agreement” shall mean any agreement between the Company or any Subsidiary and the Grantee that contains non-competition, non-solicitation, non-hire, non-disparagement, or confidentiality restrictions applicable to the Grantee.

(c)Other Remedies. The Grantee specifically acknowledges and agrees that its remedies under this Section 8 shall not prevent the Company or any Subsidiary from seeking injunctive or other equitable relief in connection with the Grantee’s breach of any Restrictive Agreement. In the event that the provisions of this Section 8 should ever be deemed to exceed the limitation provided by applicable law, then the Grantee and the Company agree that such provisions shall be reformed to set forth the maximum limitations permitted.

9.No Rights as Stockholder

The Grantee shall have no rights as a stockholder with respect to the Shares covered by the Restricted Stock Units until the effective date of issuance of the Shares and the entry of the Grantee’s name as a shareholder of record on the books of the Company following delivery of the Shares in settlement of the Restricted Stock Units.
10.Taxation Upon Settlement of the Restricted Stock Units; Tax Withholding; Parachute Tax Provisions

The Grantee understands that the Grantee will recognize income, for Federal, state and local income tax purposes, as applicable, in respect of the vesting and/or settlement of the Restricted Stock Units. The acceptance of the Shares by the Grantee shall constitute an agreement by the Grantee to report such income in accordance with then applicable law and to cooperate with Company and its subsidiaries in establishing the amount of such income and corresponding deduction to the Company and/or its subsidiaries for its income tax purposes.

The Grantee is responsible for all tax obligations that arise as a result of the vesting and settlement of the Restricted Stock Units. The Company may withhold from any amount payable to the Grantee an amount sufficient to cover any Federal, state or local withholding taxes which may become required with respect to such vesting and settlement or take any other action it deems necessary to satisfy any income or other tax withholding requirements as a result of the vesting and settlement of the Restricted Stock Units. The Company shall have the right to require the payment of any such taxes and require that the Grantee, or the Grantee’s beneficiary, to furnish information deemed necessary by the Company to meet any tax reporting obligation as a condition to delivery of any Shares pursuant to settlement of the Restricted Stock Units. The Grantee may pay his or her withholding tax obligation in connection with the vesting and settlement of the Restricted Stock Units, by making a cash payment to the Company. In



addition, the Committee, in its sole discretion, may allow the Grantee, to pay his or her withholding tax obligation in connection with the vesting and settlement of the Restricted Stock Units, by (x) having withheld a portion of the Shares then issuable to him or her upon settlement of the Restricted Stock Units or (z) surrendering Shares that have been held by the Grantee prior to the settlement of the Restricted Stock Units, in each case having an aggregate Fair Market Value equal to the amount required to be withheld in accordance with applicable tax requirements, all in accordance with such procedures as the Committee approves.

In connection with the grant of the Restricted Stock Units, the parties wish to memorialize their agreement regarding the treatment of any potential golden parachute payments as set forth in Exhibit A attached hereto.

11.Securities Laws

Upon the acquisition of any Shares pursuant to the settlement of the Restricted Stock Units, the Grantee will make such written representations, warranties, and agreements as the Committee may reasonably request in order to comply with securities laws or with this Award Agreement. Grantee hereby agrees not to offer, sell or otherwise attempt to dispose of any Shares issued to the Grantee upon settlement of the Restricted Stock Units in any way which would: (x) require the Company to file any registration statement with the Securities and Exchange Commission (or any similar filing under state law or the laws of any other county) or to amend or supplement any such filing or (y) violate or cause the Company to violate the Securities Act, the Exchange Act, the rules and regulations promulgated thereunder, or any other Federal, state or local law, or the laws of any other country. The Company reserves the right to place restrictions on any Shares the Grantee may receive as a result of the settlement of the Restricted Stock Units.

12.Modification, Amendment, and Termination of Restricted Stock Units

This Award Agreement may not be modified, amended, terminated and no provision hereof may be waived in whole or in part except by a written agreement signed by the Company and the Grantee and no modification shall, without the consent of the Grantee, alter to the Grantee’s material detriment or materially impair any rights of the Grantee under this Award Agreement except to the extent permitted under the Plan.

13.Notices

Unless otherwise provided herein, any notices or other communication given or made pursuant to the Notice, this Award Agreement or the Plan shall be in writing and shall be deemed to have been duly given (i) as of the date delivered, if personally delivered (including receipted courier service) or overnight delivery service, with confirmation of receipt; (ii) on the date the delivering party receives confirmation, if delivered by facsimile to the number indicated or by email to the address indicated or through an electronic administrative system designated by the Company; (iii) one (1) business day after being sent by reputable commercial overnight delivery service courier, with confirmation of receipt; or (iv) three (3) business days after being mailed by



registered or certified mail, return receipt requested, postage prepaid and addressed to the intended recipient as set forth below:
If to the Company at the address below:

    GMS Inc.
100 Crescent Centre Parkway, Suite 800
Tucker, Georgia 30084
Phone: (800) 392-4619
Attention: General Counsel
If to the Grantee, at the most recent address, facsimile number or email contained in the Company’s records.

14.Award Agreement Subject to Plan and Applicable Law

This Award Agreement is made pursuant to the Plan and shall be interpreted to comply therewith. A copy of the Plan is attached hereto. Any provision of this Award Agreement inconsistent with the Plan shall be considered void and replaced with the applicable provision of the Plan. The Plan shall control in the event there shall be any conflict between the Plan, the Notice, and this Award Agreement, and it shall control as to any matters not contained in this Award Agreement. The Committee shall have authority to make constructions of this Award Agreement, and to correct any defect or supply any omission or reconcile any inconsistency in this Award Agreement, and to prescribe rules and regulations relating to the administration of this Award and other Awards granted under the Plan.

This Award Agreement shall be governed by the laws of the State of Delaware, without regard to the conflicts of law principles thereof, and subject to the exclusive jurisdiction of the courts therein. The Grantee hereby consents to personal jurisdiction in any action brought in any court, federal or state, within the State of Delaware having subject matter jurisdiction in the matter.

15.Section 409A

To the maximum extent permitted, the Restricted Stock Units and this Award Agreement shall be interpreted to be exempt from Section 409A of the Code or, if not exempt, in compliance therewith. Nothing contained herein shall constitute any representation or warranty by the Company regarding compliance with Section 409A of the Code. The Company shall have no obligation to take any action to prevent the assessment of any additional income tax, interest or penalties under Section 409A of the Code on any Person and the Company, its Subsidiaries and affiliates, and each of their respective employees and representatives, shall have no liability to the Grantee with respect thereto.

Notwithstanding anything in this Award Agreement to the contrary, to the extent that the Restricted Stock Units constitute non-exempt deferred compensation for purposes of Section 409A of the Code, the following shall apply: (i) references herein to “Change in Control”



and “termination of employment” shall mean the description or definition of “change in control event” or “separation from service”, respectively, in Section 409A of the Code and applicable regulations; and (ii) if the Restricted Stock Units become payable by reason of the Grantee’s separation from service during a period in which the Grantee is a “specified employee” (as defined in Section 409A of the Code), then the Restricted Stock Units that would otherwise be payable during the six-month period immediately following the Grantee’s separation from service will be accumulated through and paid or provided on the first day of the seventh month following the Grantee’s separation from service.

16.Headings and Capitalized Terms

Unless otherwise provided herein, capitalized terms used herein that are defined in the Plan and not defined herein shall have the meanings set forth in the Plan. Headings are for convenience only and are not deemed to be part of this Award Agreement. Unless otherwise indicated, any reference to a Section herein is a reference to a Section of this Award Agreement.
17.Severability and Reformation

If any provision of this Award Agreement shall be determined by a court of law of competent jurisdiction to be unenforceable for any reason, such unenforceability shall not affect the enforceability of any of the remaining provisions hereof; and this Award Agreement, to the fullest extent lawful, shall be reformed and construed as if such unenforceable provision, or part thereof, had never been contained herein, and such provision or part thereof shall be reformed or construed so that it would be enforceable to the maximum extent legally possible.

18.Binding Effect

This Award Agreement shall be binding upon the parties hereto, together with their personal executors, administrator, successors, personal representatives, heirs and permitted assigns.

19.Entire Agreement

This Award Agreement, together with the Plan, supersedes all prior written and oral agreements and understandings among the parties as to its subject matter and constitutes the entire agreement of the parties with respect to the subject matter hereof. If there is any conflict between the Notice, this Award Agreement and the Plan, then the applicable terms of the Plan shall govern.
20.Waiver

Waiver by any party of any breach of this Award Agreement or failure to exercise any right hereunder shall not be deemed to be a waiver of any other breach or right whether or not of the same or a similar nature. The failure of any party to take action by reason of such breach or to exercise any such right shall not deprive the party of the right to take action at any time while or after such breach or condition giving rise to such rights continues.




Exhibit A

PARACHUTE TAX PROVISIONS

This Exhibit A sets forth the terms and provisions applicable to the Grantee pursuant to the provisions of Section 10 of the Award Agreement. This Exhibit A shall be subject in all respects to the terms and conditions of the Award Agreement.

(a)    To the extent that the Grantee, would otherwise be eligible to receive a payment or benefit pursuant to the terms of this Award Agreement, any employment or other agreement with the Company or any Subsidiary or otherwise in connection with, or arising out of, the Grantee’s employment with the Company or a change in ownership or effective control of the Company or of a substantial portion of its assets (any such payment or benefit, a “Parachute Payment”), that a nationally recognized United States public accounting firm selected by the Company (the “Accountants”) determines, but for this sentence would be subject to excise tax imposed by Section 4999 of the Code (the “Excise Tax”), subject to clause (c) below, then the Company shall pay to the Grantee whichever of the following two alternative forms of payment would result in the Grantee’s receipt, on an after-tax basis, of the greater amount of the Parachute Payment notwithstanding that all or some portion of the Parachute Payment may be subject to the Excise Tax: (1) payment in full of the entire amount of the Parachute Payment (a “Full Payment”), or (2) payment of only a part of the Parachute Payment so that the Grantee receives the largest payment possible without the imposition of the Excise Tax (a “Reduced Payment”).

(b)    If a reduction in the Parachute Payment is necessary pursuant to clause (a), then the reduction shall occur in the following order: (1) cancellation of acceleration of vesting on any equity awards for which the exercise price exceeds the then fair market value of the underlying equity; (2) reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they would otherwise be made, that is, later payments shall be reduced before earlier payments); and (3) cancellation of acceleration of vesting of equity awards not covered under (1) above; provided, however, that in the event that acceleration of vesting of equity awards is to be cancelled, acceleration of vesting of full value awards shall be cancelled before acceleration of options and stock appreciation rights and within each class such acceleration of vesting shall be cancelled in the reverse order of the date of grant of such equity awards, that is, later equity awards shall be canceled before earlier equity awards; and provided, further, that to the extent permitted by Code Section 409A and Sections 280G and 4999 of the Code, if a different reduction procedure would be permitted without violating Code Section 409A or losing the benefit of the reduction under Sections 280G and 4999 of the Code, the Grantee may designate a different order of reduction.

(c)    For purposes of determining whether any of the Parachute Payments (collectively the “Total Payments”) will be subject to the Excise Tax and the amount of such Excise Tax, (i) the Total Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base amount” (as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the opinion of the Accountants, such Total Payments (in



whole or in part): (1) do not constitute “parachute payments,” including giving effect to the recalculation of stock options in accordance with Treasury Regulation Section 1.280G-1, Q&A 33, (2) represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the “base amount” or (3) are otherwise not subject to the Excise Tax, and (ii) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants in accordance with the principles of Section 280G of the Code.

(d)    All determinations hereunder shall be made by the Accountants, which determinations shall be final and binding upon the Company and the Grantee.

(e)    The federal tax returns filed by the Grantee (and any filing made by a consolidated tax group which includes the Company) shall be prepared and filed on a basis consistent with the determination of the Accountants with respect to the Excise Tax payable by the Grantee. The Grantee shall make proper payment of the amount of any Excise Tax, and at the request of the Company, provide to the Company true and correct copies (with any amendments) of his or her federal income tax return as filed with the Internal Revenue Service, and such other documents reasonably requested by the Company, evidencing such payment (provided that the Grantee may delete information unrelated to the Parachute Payment or Excise Tax and provided, further that the Company at all times shall treat such returns as confidential and use such return only for purpose contemplated by this paragraph).

(f)    In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the Grantee shall permit the Company to control issues related to the Excise Tax (at its expense), provided that such issues do not potentially materially adversely affect the Grantee but the Grantee shall control any other issues. In the event that the issues are interrelated, the Grantee and the Company shall in good faith cooperate so as not to jeopardize resolution of either issue. In the event of any conference with any taxing authority as to the Excise Tax or associated income taxes, the Grantee shall permit the representative of the Company to accompany the Grantee, and the Grantee and his representative shall cooperate with the Company and its representative.

(g)    The Company shall be responsible for all charges of the Accountants.

(h)    The Company and the Grantee shall promptly deliver to each other copies of any written communications, and summaries of any verbal communications, with any taxing authority regarding the Excise Tax covered by this Exhibit A.

(i)    Nothing in this Exhibit A is intended to violate the Sarbanes-Oxley Act of 2002 and to the extent that any advance or repayment obligation hereunder would do so, such obligation shall be modified so as to make the advance a nonrefundable payment to the Grantee and the repayment obligation null and void.

(j)    Notwithstanding the foregoing, any payment or reimbursement made pursuant to this Exhibit A shall be paid to the Grantee promptly and in no event later than the end of the



calendar year next following the calendar year in which the related tax is paid by the Grantee or where no taxes are required to be remitted, the end of the Grantee’s calendar year following the Grantee’s calendar year in which the audit is completed or there is a final and nonappealable settlement or other resolution of the litigation.

(k)    The provisions of this Exhibit A shall survive the termination of the Grantee’s employment with the Company for any reason and the termination of the Award Agreement.




Exhibit B

RESTRICTIVE COVENANTS

This Exhibit B contains the Restrictive Covenants applicable to the Grantee if the Grantee agrees to be bound by the Restrictive Covenants as a condition to receipt of the benefits set forth in Section 6(a) of the Award Agreement.

1.    Unauthorized Disclosure. The Grantee agrees and understands that in the Grantee’s position with the Company, the Grantee has and shall be exposed to and has and shall receive information relating to the confidential affairs of the Company and its direct and indirect subsidiaries and affiliates (the “Company Group”), including, without limitation, technical information, intellectual property, business and marketing plans, strategies, customer information, software, other information concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company Group and other forms of information considered by the Company Group to be confidential or in the nature of trade secrets (including, without limitation, ideas, research and development, know-how, formulas, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and marketing plans and proposals) (collectively, the “Confidential Information”). Confidential Information shall not include information that is generally known to the public or within the relevant trade or industry other than due to the Grantee’s violation of this Section 1 of Exhibit B or disclosure by a third party who is known by the Grantee to owe the Company an obligation of confidentiality with respect to such information. The Grantee agrees that at all times during the Grantee’s employment with the Company and thereafter, the Grantee shall not disclose such Confidential Information, either directly or indirectly, to any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof (each a “Person”) without the prior written consent of the Company and shall not use or attempt to use any such information in any manner other than in connection with the Grantee’s employment with the Company, unless required by law to disclose such information, in which case the Grantee shall provide the Company with written notice of such requirement as far in advance of such anticipated disclosure as possible. This confidentiality covenant has no temporal, geographical or territorial restriction. The Grantee understands and acknowledges that nothing in this section limits the Grantee’s ability to report possible violations of federal, state, or local law or regulation to any governmental agency or entity; to communicate with any government agencies or otherwise participate in any investigation or proceeding that may be conducted by any government agencies in connection with any charge or complaint, whether filed by the Grantee, on the Grantee’s behalf, or by any other individual; or to make other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and the Grantee shall not need the prior authorization of the Company to make any such reports or disclosures and shall not be required to notify the Company that the Grantee has made such reports or disclosures. In addition, and anything herein to the contrary notwithstanding, the Grantee is hereby given notice that the Grantee shall not be criminally or civilly liable under any federal or state trade secret law for disclosing a trade secret (as defined by 18 U.S.C. § 1839) in confidence to a federal, state, or



local government official, either directly or indirectly, or to an attorney, in either event solely for the purpose of reporting or investigating a suspected violation of law; or disclosing a trade secret (as defined by 18 U.S.C. § 1839) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
2.    Return of Property. Upon termination of the Grantee’s employment with the Company, the Grantee shall promptly supply to the Company all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data and any other tangible product or document which has been produced by, received by or otherwise submitted to the Grantee during or prior to the Grantee’s employment with the Company, and any copies thereof in the Grantee’s (or reasonably capable of being reduced to the Grantee’s) possession; provided that nothing in this Award Agreement or elsewhere shall prevent the Grantee from retaining and utilizing: documents relating to the Grantee’s personal benefits, entitlements and obligations; documents relating to the Grantee’s personal tax obligations; the Grantee’s desk calendar, rolodex, and the like; and such other records and documents as may reasonably be approved by the Company. To the extent that the Grantee has electronic files or information in the Grantee’s possession or control that belong to the Company or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile devices, electronic media, or in cloud storage), on or prior to Grantee’s Termination, or at any other time the Company requests, the Grantee shall (i) provide the Company with an electronic copy of all of such files or information (in an electronic format that readily accessible by the Company); (ii) after doing so, delete all such files and information, including all copies and derivatives thereof, from all non-Company-owned computers, mobile devices, electronic media, cloud storage, and other media, devices, and equipment, such that such files and information are permanently deleted and irretrievable; and (iii) provide a written certification to the Company that the required deletions have been completed and specifying the files and information deleted and the media source from which they were deleted.
3.    Non-Competition. By and in consideration of the Company’s grant of the Restricted Stock Units, and in further consideration of the Grantee’s exposure to the Confidential Information of the Company Group, the Grantee agrees that the Grantee shall not, during Grantee’s employment with the Company and for twelve (12) months following the Grantee’s Termination (the “Restriction Period”), directly or indirectly, own, manage, operate, join, control, be employed by, or participate in the ownership, management, operation or control of, or be connected in any manner with, including, without limitation, holding any position as a stockholder, director, officer, consultant, independent contractor, employee, partner, or investor in, any Restricted Enterprise (as defined below); provided, that in no event shall ownership of one percent or less of the outstanding securities of any class of any issuer whose securities are registered under the Securities Exchange Act of 1934, as amended, standing alone, be prohibited by this Section 3 of Exhibit B, so long as the Grantee does not have, or exercise, any rights to manage or operate the business of such issuer other than rights as a stockholder thereof. For purposes of this paragraph, “Restricted Enterprise” shall mean any Person that is actively engaged in any geographic area in which any member of the Company Group operates or markets in any business which is in material competition with the business of any member of the



Company Group. During the Restriction Period, upon request of the Company, the Grantee shall notify the Company of the Grantee’s then-current employment status.
4.    Non-Solicitation of Employees. During the Restriction Period, the Grantee shall not directly or indirectly contact, induce or solicit (or assist any Person to contact, induce or solicit) for employment any person who is, or within twelve (12) months prior to the date of such solicitation was, an employee of any member of the Company Group other than an employee (a) whose employment was involuntarily terminated by a member of the Company Group after the Grantee’s Termination and (b) who has not been an employee of the Company Group for six months or longer. The foregoing restriction shall not apply to the placement of general advertisements or other notices of employment opportunities that are not targeted, directly or indirectly, to any current or former employee of the Company otherwise covered by the scope of such restriction so long as the Grantee is not personally involved in the recruitment or hiring of any such employee subsequent to such general advertisement or other notice.
5.    Interference with Business Relationships. During the Restriction Period (other than in connection with carrying out the Grantee’s responsibilities for the Company Group), the Grantee shall not directly or indirectly induce or solicit (or assist any Person to induce or solicit) any customer or client of any member of the Company Group to terminate its relationship or otherwise cease doing business in whole or in part with any member of the Company Group, or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship between any member of the Company Group and any of their customers or clients so as to cause harm to any member of the Company Group.
6.    Extension of Restriction Period. The Restriction Period shall be tolled for any period during which the Grantee is in breach of any of Sections 3, 4 or 5 of this Exhibit B.
7.    Proprietary Rights. The Grantee shall disclose promptly to the Company any and all inventions, discoveries, and improvements (whether or not patentable or registrable under copyright or similar statutes), and all patentable or copyrightable works, initiated, conceived, discovered, reduced to practice, or made by the Grantee, either alone or in conjunction with others, during the Grantee’s employment with the Company and related to the business or activities of the Company Group (the “Developments”). Except to the extent any rights in any Developments constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq. that are owned ab initio by a member of the Company Group, the Grantee assigns and agrees to assign all of the Grantee’s right, title and interest in all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including all rights or benefits therefor, including without limitation the right to sue and recover for past and future infringement. The Grantee acknowledges that any rights in any Developments constituting a work made for hire under the U.S. Copyright Act, 17 U.S.C § 101 et seq. are owned upon creation by the Company as the Grantee’s employer. Whenever requested to do so by the Company, the Grantee shall execute any and all applications, assignments or other instruments which the Company shall deem necessary to apply for and obtain trademarks, patents or copyrights of the United States or any foreign country or otherwise protect the interests of the Company Group. These obligations shall continue beyond the end of



the Grantee’s employment with the Company with respect to inventions, discoveries, improvements or copyrightable works initiated, conceived or made by the Grantee while employed by the Company, and shall be binding upon the Grantee’s employers, assigns, executors, administrators and other legal representatives. If the Company is unable for any reason, after reasonable effort, to obtain the Grantee’s signature on any document needed in connection with the actions described in this Section 7 of Exhibit B, the Grantee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Grantee’s agent and attorney in fact to act for and on the Grantee’s behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of this Section 7 of Exhibit B with the same legal force and effect as if executed by the Grantee.
8.    Remedies. The Grantee agrees that any breach of the terms of the Restrictive Covenants contained in this Exhibit B would result in irreparable injury and damage to the Company Group for which the Company would have no adequate remedy at law; the Grantee therefore also agrees that in the event of said breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent such breach and/or threatened breach and/or continued breach by the Grantee and/or any and all Persons acting for and/or with the Grantee, without having to prove damages, in addition to any other remedies to which the Company may be entitled at law or in equity. The terms of this paragraph shall not prevent the Company from pursuing any other available remedies for any breach or threatened breach hereof, including, without limitation, the recovery of damages from the Grantee. The Grantee and the Company further agree that the provisions of the covenants contained in this Exhibit B are reasonable and necessary to protect the businesses of the Company Group because of the Grantee’s access to Confidential Information and the Grantee’s material participation in the operation of such businesses. In the event that the Grantee willfully and materially breaches any of the covenants set forth in this Exhibit B, then in addition to any injunctive relief, the Grantee shall forfeit the unvested Restricted Stock Units in their entirety.
9.    Applicable Law; Forum Selection; Consent to Jurisdiction. The Company and the Grantee agree that, notwithstanding anything in this Award Agreement to the contrary, this Exhibit B shall be governed by and construed and interpreted in accordance with the laws of the State of Georgia without giving effect to its conflicts of law principles. The Grantee agrees that the exclusive forum for any action to enforce this Exhibit B, as well as any action relating to or arising out of this Exhibit B, shall be the federal and state courts of the State of Georgia. With respect to any such court action, the Grantee hereby irrevocably submits to the personal jurisdiction of such courts. The Company and the Grantee hereto further agree that the courts listed above are convenient forums for any dispute that may arise herefrom and that neither party shall raise as a defense that such courts are not convenient forums.
10.    Non-Disparagement. From and after the date of grant and following the Grantee’s Termination, the Grantee agrees not to make any statement, whether direct or indirect, whether true or false, that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory of the Company, any of its subsidiaries, affiliates, employees, officers, directors or stockholders. This Section 10 of Exhibit B shall not in any way limit any of the protected rights contained in the last two



sentences of Section 1 of Exhibit B of this Award Agreement, or the Grantee’s ability to provide truthful testimony pursuant to a subpoena, court order or as otherwise required by law.
11.    Survival. The obligations of the Grantee under this Exhibit B shall survive the termination of this Award Agreement and the Grantee’s Termination for the periods expressly designated in this Exhibit B or, if no such period is designated, for the maximum period permissible under applicable law.




Exhibit 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John C. Turner, Jr., certify that:
1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended July 31, 2021 of GMS Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: September 2, 2021 /s/ John C. Turner, Jr.
John C. Turner, Jr.
Chief Executive Officer, President and Director
(Principal Executive Officer)






Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Scott M. Deakin, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended July 31, 2021 of GMS Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: September 2, 2021 /s/ Scott M. Deakin
Scott M. Deakin
Chief Financial Officer
(Principal Financial Officer)






Exhibit 32.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of GMS Inc., a Delaware corporation (the "Company"), for the quarter ended July 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), John C. Turner, Jr., Chief Executive Officer, President and Director of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: September 2, 2021 /s/ John C. Turner, Jr.
John C. Turner, Jr.
Chief Executive Officer, President and Director
(Principal Executive Officer)



Exhibit 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of GMS Inc., a Delaware corporation (the "Company"), for the quarter ended July 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Scott M. Deakin, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: September 2, 2021 /s/ Scott M. Deakin
Scott M. Deakin
Chief Financial Officer
(Principal Financial Officer)